<?xml version="1.0" encoding="UTF-8"?>
<Bundle xmlns="http://hl7.org/fhir">
    <id value="0009-7166-3cbb485b-6df1-49ce-8747-592b395b1988" />
    <meta>
    <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/ProductSubmissionBundle" />
    </meta>
    <identifier>
        <system value="urn:ietf:rfc:3986" />
        <value value="urn:uuid:390bdccc-18c4-4f26-adda-388273c9dfd0" />
    </identifier>
    <type value="document" />
    <timestamp value="2024-04-09T00:00:00.0000Z" />
    <entry>
        <fullUrl value="http://example.org/Composition/ProductComposition" />
        <resource>
            <Composition>
                <id value="ProductComposition" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/ProductSubmissionDocument" />
                </meta>
                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/versionNumber">
                    <valueString value="11" />
                </extension>
                <identifier>
                    <system value="urn:ietf:rfc:3986" />
                    <value value="urn:uuid:3cbb485b-6df1-49ce-8747-592b395b1988" />
                </identifier>
                <status value="final" />
                <type>
                    <coding>
                        <system value="http://loinc.org" /><code value="34391-3" />
                        <display value="HUMAN PRESCRIPTION DRUG LABEL" />
                    </coding>
                </type>
                <date value="2024-04-09" />
                <author>
                    <reference value="Organization/Labeler-618054084" />
                </author>
                <title
                    value="These highlights do not include all the information needed to use SOMAVERT safely and effectively. See full prescribing information for SOMAVERT.SOMAVERT (pegvisomant) for injection, for subcutaneous use Initial U.S. Approval: 2003" />
                <section id="b78b2816-012d-4a49-af07-4e744bf4d704">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2024-04-09" />
                    </extension>
                    <code><coding><system value="http://loinc.org" /><code value="48780-1" /><display value="SPL LISTING DATA ELEMENTS SECTION" /></coding></code>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-7166" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5175" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5936" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-7168" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5177" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-7188" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5179" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-7199" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5201" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-7200" />
                    </entry>
                    <entry>
                        <reference value="MedicinalProductDefinition/0009-5376" />
                    </entry>
                </section>
                <section id="d8aac69f-0109-4921-9201-f52b4377341e">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S1" />
                    </extension>
                    <title value="1 INDICATIONS AND USAGE" />
                    <code><coding><system value="http://loinc.org" /><code value="34067-9" /><display value="INDICATIONS &amp; USAGE SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>SOMAVERT is a growth hormone receptor antagonist indicated for the treatment of
                                    acromegaly in patients who have had an inadequate response to surgery or radiation
                                    therapy, or for whom these therapies are not appropriate. The goal of treatment is
                                    to normalize serum insulin-like growth factor-1 (IGF-1) levels. (<a
                                        href="#ID_RefS1">1</a>)</p>
                            </div>
                            <div style="narrative">
                                <p>SOMAVERT is indicated for the treatment of acromegaly in patients who have had an
                                    inadequate response to surgery or radiation therapy, or for whom these therapies are
                                    not appropriate. The goal of treatment is to normalize serum insulin-like growth
                                    factor-1 (IGF-1) levels.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="8472d073-6ec5-4c85-ac02-df788d321e36">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S2" />
                    </extension>
                    <title value="2 DOSAGE AND ADMINISTRATION" />
                    <code><coding><system value="http://loinc.org" /><code value="34068-7" /><display value="DOSAGE &amp; ADMINISTRATION SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>
                                        <p>Administer a 40 mg loading dose subcutaneously under physician supervision.
                                            (<a href="#ID_RefS2.1">2.1</a>)</p>
                                    </li>
                                    <li>
                                        <p>After proper injection instruction, on day after loading dose, patients or
                                            caregivers begin daily subcutaneous injections of 10 mg. (<a
                                                href="#ID_RefS2.1">2.1</a>)</p>
                                    </li>
                                    <li>
                                        <p>Adjust dosage in 5 mg increments or decrements until serum IGF-1
                                            concentrations are maintained within age-adjusted normal range. Do not
                                            adjust dosage based on growth hormone (GH) levels or signs or symptoms of
                                            acromegaly. (<a href="#ID_RefS2.1">2.1</a>)</p>
                                    </li>
                                    <li>
                                        <p>Dosage range is 10 mg to 30 mg once daily. (<a href="#ID_RefS2.1">2.1</a>)
                                        </p>
                                    </li>
                                    <li>
                                        <p>Perform liver tests prior to first dosage and if greater than 3 times upper
                                            limit of normal should work-up prior to SOMAVERT administration. (<a
                                                href="#ID_RefS2.2">2.2</a>)</p>
                                    </li>
                                    <li>
                                        <p>Follow reconstitution and injection procedures. (<a
                                                href="#ID_RefS2.3">2.3</a>, <a href="#ID_RefS2.4">2.4</a>)</p>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="7edccd2f-80a1-4c69-902b-6f8f10b5acd8">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.1" />
                        </extension>
                        <title value="2.1Dosage Information" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The recommended loading dose of SOMAVERT is 40 mg given subcutaneously, under
                                        healthcare provider supervision. Provide proper training in subcutaneous
                                        injection technique to patients or their caregivers so they can receive once
                                        daily subcutaneous injections. On the next day following the loading dose,
                                        instruct patients or their caregivers to begin daily subcutaneous injections of
                                        10 mg of SOMAVERT.</p>
                                    <p>Titrate the dosage to normalize serum IGF-1 concentrations (serum IGF-1
                                        concentrations should be measured every four to six weeks). The dosage should
                                        not be based on growth hormone (GH) concentrations or signs and symptoms of
                                        acromegaly. It is unknown whether patients who remain symptomatic while
                                        achieving normalized IGF-1 concentrations would benefit from increased SOMAVERT
                                        dosage.</p>
                                    <ul>
                                        <li>
                                            <p id="_RefS2.1">Increase the dosage by 5 mg increments every 4–6 weeks if
                                                IGF-1 concentrations are elevated.</p>
                                        </li>
                                        <li>
                                            <p>Decrease the dosage by 5 mg decrements every 4–6 weeks if IGF-1
                                                concentrations are below the normal range.</p>
                                        </li>
                                        <li>
                                            <p>IGF-1 levels should also be monitored when a SOMAVERT dose given in
                                                multiple injections is converted to a single daily injection <i>[see <a
                                                        href="#ID_RefS12">Clinical Pharmacology (12)</a>]</i>.</p>
                                        </li>
                                    </ul>
                                    <p>The recommended dosage range is between 10 mg to 30 mg given subcutaneously once
                                        daily and the maximum daily dosage is 30 mg given subcutaneously once daily.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="066827f3-35c3-4306-a572-b9b321b38116">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.2" />
                        </extension>
                        <title value="2.2Assess Liver Tests Prior to Initiation of SOMAVERT" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Prior to the start of SOMAVERT, patients should have an assessment of baseline
                                        levels of liver tests [serum alanine aminotransferase (ALT), aspartate
                                        aminotransferase (AST), serum total bilirubin (TBIL), and alkaline phosphatase
                                        (ALP)]. For recommendations regarding initiation of SOMAVERT based on baseline
                                        liver tests and recommendations for monitoring of liver tests while on SOMAVERT,
                                        refer to Table 1 in <i><a href="#ID_RefS5.2">Warning and Precautions
                                                (5.2)</a></i>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="141ebe51-a1b3-462e-a993-43ca68383a08">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.3" />
                        </extension>
                        <title value="2.3Loading Dose Injection Procedure" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The following instructions are for the <b>healthcare provider</b> to reconstitute
                                        and prepare the 40 mg loading dose. The healthcare provider will need to
                                        reconstitute 2 vials of lyophilized powder of SOMAVERT each containing 20 mg of
                                        pegvisomant with supplied diluent [two vials of lyophilized powder and two
                                        syringes containing 1 mL of diluent (Sterile Water for Injection, USP) will be
                                        needed for the 40 mg loading dose]. The healthcare provider will also need to
                                        inject the reconstituted SOMAVERT solution twice into the patient's upper arm,
                                        upper thigh, abdomen, or buttocks (each injection in a different area).</p>
                                    <ol>
                                        <li>
                                            <p id="_RefS2.3">Before administering the loading dose, remove 1 vial of
                                                lyophilized powder of SOMAVERT containing 20 mg of pegvisomant and one
                                                syringe containing 1 mL of diluent from the refrigerator, if
                                                refrigerated, about 10 minutes prior to the planned injection time.</p>
                                        </li>
                                        <li>
                                            <p>Reconstitute the first 20 mg vial of lyophilized powder of SOMAVERT
                                                containing 20 mg of pegvisomant with diluent. When using the diluent in
                                                the syringe, inject the contents of the syringe slowly onto the sides of
                                                the vial containing lyophilized powder of SOMAVERT. Do not inject the
                                                diluent directly on the powder.</p>
                                        </li>
                                        <li>
                                            <p>Do not invert the vial or shake the solution as this may cause
                                                denaturation of the pegvisomant protein. Slowly swirl the solution to
                                                ensure that all of the lyophilized powder has gone into solution. If
                                                foaming of the reconstituted SOMAVERT solution is seen, the solution is
                                                likely damaged and therefore inappropriate to inject.</p>
                                        </li>
                                        <li>
                                            <p>Visually inspect the reconstituted SOMAVERT solution for particulate
                                                matter and discoloration prior to administration. The reconstituted
                                                solution should be clear. If the solution is cloudy, do not use it. Once
                                                reconstituted, the solution will contain 20 mg of pegvisomant in 1 mL of
                                                solution.</p>
                                        </li>
                                        <li>
                                            <p>Withdraw the 1 mL reconstituted SOMAVERT solution. The solution must be
                                                administered immediately after reconstitution.</p>
                                        </li>
                                        <li>
                                            <p>Inject the first reconstituted SOMAVERT solution (20 mg/mL)
                                                subcutaneously into the patient's upper arm, upper thigh, abdomen, or
                                                buttocks using a 90-degree angle.</p>
                                        </li>
                                        <li>
                                            <p>Repeat steps (a) to (e) to reconstitute the second SOMAVERT dose of 20mg.
                                            </p>
                                        </li>
                                        <li>
                                            <p>Finally, inject the second reconstituted SOMAVERT solution (20 mg/mL)
                                                subcutaneously into the patient's upper arm, upper thigh, abdomen, or
                                                buttocks using a 90-degree angle (different area than the first
                                                injection).</p>
                                        </li>
                                    </ol>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="0dff3304-746e-408c-bbc3-4ceb4c25c30f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S2.4" />
                        </extension>
                        <title value="2.4Maintenance Dose Injection Procedure" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>For patient or caregiver instructions for reconstitution and administration of
                                        daily doses (10 mg to 30 mg), see the <a href="#ID_RefIFU">Patient's
                                            Instructions for Use</a>. </p>
                                    <ol>
                                        <li>
                                            <p id="_RefS2.4">Before administering the dose, remove 1 vial of lyophilized
                                                powder of SOMAVERT containing 10 mg, 15 mg, 20 mg, 25 mg or 30 mg of
                                                pegvisomant and one syringe containing 1 mL of diluent from the
                                                refrigerator, if refrigerated, about 10 minutes prior to the planned
                                                injection time.</p>
                                        </li>
                                        <li>
                                            <p>Reconstitute the lyophilized powder of SOMAVERT with diluent. When using
                                                the diluent in the 2.25 mL syringe, inject the contents of the syringe
                                                slowly onto the sides of the vial containing lyophilized powder of
                                                SOMAVERT. Do not inject the diluent directly on the powder.</p>
                                        </li>
                                        <li>
                                            <p>Do not invert the vial or shake the solution as this may cause
                                                denaturation of the pegvisomant protein. Slowly swirl the solution to
                                                ensure that all of the lyophilized powder has gone into solution. If
                                                foaming of the reconstituted SOMAVERT solution is seen, the solution is
                                                likely damaged and therefore inappropriate to inject.</p>
                                        </li>
                                        <li>
                                            <p>Visually inspect the reconstituted SOMAVERT solution for particulate
                                                matter and discoloration prior to administration. The reconstituted
                                                solution should be clear. If the solution is cloudy, do not use it. Once
                                                reconstituted, the solution will contain 10 mg, 15 mg, 20 mg, 25 mg or
                                                30 mg of pegvisomant in 1 mL of solution.</p>
                                        </li>
                                        <li>
                                            <p>Withdraw the 1 mL reconstituted SOMAVERT solution. The solution must be
                                                administered immediately after reconstitution.</p>
                                        </li>
                                        <li>
                                            <p>Inject the reconstituted SOMAVERT solution subcutaneously into the upper
                                                arm, upper thigh, abdomen, or buttocks using a 90-degree angle.</p>
                                        </li>
                                    </ol>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="f0d19c65-1973-4edd-9c27-13c311c0fa9b">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S3" />
                    </extension>
                    <title value="3 DOSAGE FORMS AND STRENGTHS" />
                    <code><coding><system value="http://loinc.org" /><code value="43678-2" /><display value="DOSAGE FORMS &amp; STRENGTHS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>For injection: 10 mg, 15 mg, 20 mg, 25 mg or 30 mg lyophilized powder in a
                                    single-dose vial for reconstitution supplied with a prefilled syringe containing 1
                                    mL of diluent (Sterile Water for Injection, USP). (<a href="#ID_RefS3">3</a>)</p>
                            </div>
                            <div style="narrative">
                                <p>For injection: 10 mg, 15 mg, 20 mg, 25 mg or 30 mg white lyophilized powder in a
                                    single-dose vial for reconstitution supplied with a prefilled syringe containing 1
                                    mL of diluent (Sterile Water for Injection, USP).</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="b61d1864-5ba4-4700-8dbe-a66f731220f0">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S4" />
                    </extension>
                    <title value="4 CONTRAINDICATIONS" />
                    <code><coding><system value="http://loinc.org" /><code value="34070-3" /><display value="CONTRAINDICATIONS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p>None. (<a href="#ID_RefS4">4</a>)</p>
                            </div>
                            <div style="narrative">
                                <p>None.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="9ffa1a35-bbf0-4e82-9ea6-75c1866d00b6">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S5" />
                    </extension>
                    <title value="5 WARNINGS AND PRECAUTIONS" />
                    <code><coding><system value="http://loinc.org" /><code value="43685-7" /><display value="WARNINGS AND PRECAUTIONS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>
                                        <p><i>Hypoglycemia</i>: Monitor blood glucose in patients with diabetes mellitus
                                            and reduce anti-diabetic drug therapy as necessary. (<a
                                                href="#ID_RefS5.1">5.1</a>)</p>
                                    </li>
                                    <li>
                                        <p><i>Liver Toxicity:</i> Should have more frequent liver tests and/or
                                            discontinue SOMAVERT. (<a href="#ID_RefS5.2">5.2</a>)</p>
                                    </li>
                                    <li>
                                        <p><i>Systemic Hypersensitivity</i>: Monitor closely when re-initiating SOMAVERT
                                            in patients with systemic hypersensitivity. (<a href="#ID_RefS5.5">5.5</a>)
                                        </p>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="c5c60515-c5b2-4097-9d63-108d385827b3">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.1" />
                        </extension>
                        <title value="5.1Hypoglycemia Associated With GH Lowering in Patients With Diabetes Mellitus" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>GH opposes the effects of insulin on carbohydrate metabolism by decreasing
                                        insulin sensitivity; thus, glucose tolerance may improve in some patients
                                        treated with SOMAVERT. Patients should be carefully monitored and doses of
                                        anti-diabetic drugs reduced as necessary to avoid hypoglycemia in patients with
                                        diabetes mellitus.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="83c40a70-f379-4215-900f-c886e9e9175a">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.2" />
                        </extension>
                        <title value="5.2Liver Toxicity" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Baseline serum alanine aminotransferase (ALT), aspartate aminotransferase (AST),
                                        serum total bilirubin (TBIL), and alkaline phosphatase (ALP) levels should be
                                        obtained prior to initiating therapy with SOMAVERT. Table 1 lists
                                        recommendations regarding initiation of treatment with SOMAVERT, based on the
                                        results of these liver tests (LTs).</p>
                                    <p>Asymptomatic, transient elevations in transaminases up to 15 times ULN have been
                                        observed in &lt;2% of subjects among two open-label trials (with a total of 147
                                        patients). These reports were not associated with an increase in bilirubin.
                                        Transaminase elevations normalized with time, most often after suspending
                                        treatment. Postmarketing reports have identified elevations in serum hepatic
                                        transaminases up to greater than 20 times ULN associated with elevation in total
                                        bilirubin greater than 2 times ULN. In many of these cases, discontinuation of
                                        SOMAVERT therapy resulted in improvement or resolution of hepatic laboratory
                                        abnormalities.</p>
                                    <p>SOMAVERT should be used in accordance with the information presented in Table 2
                                        with respect to liver test abnormalities while on SOMAVERT treatment.</p>
                                    <table width="75%">
                                        <caption>Table 1. Recommendations of Initiating SOMAVERT Based on Baseline LTs
                                            and Periodic Monitoring of LTs During SOMAVERT Treatment</caption>
                                        <colgroup span="2">
                                            <col width="34%" />
                                            <col width="53%" />
                                        </colgroup>
                                        <thead>
                                            <tr>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                    <b>Baseline LT Levels</b></th>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                    <b>Recommendations</b></th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                    <p>Normal</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                    <ul>
                                                        <li>
                                                            <p>May treat with SOMAVERT.</p>
                                                        </li>
                                                        <li>
                                                            <p>Monitor LTs at monthly intervals during the first 6
                                                                months of treatment, quarterly for the next 6 months and
                                                                then bi-annually for the next year.</p>
                                                        </li>
                                                    </ul>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Elevated, but less than or equal to 3 times ULN</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p>May treat with SOMAVERT; however, monitor LTs monthly for at
                                                        least one year after initiation of therapy and then bi-annually
                                                        for the next year.</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; border-left: solid; ">
                                                    <p>Greater than 3 times ULN</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <ul>
                                                        <li>
                                                            <p>Do not treat with SOMAVERT until a comprehensive workup
                                                                establishes the cause of the patient's liver
                                                                dysfunction.</p>
                                                        </li>
                                                        <li>
                                                            <p>Determine if cholelithiasis or choledocholithiasis is
                                                                present, particularly in patients with a history of
                                                                prior therapy with somatostatin analogs.</p>
                                                        </li>
                                                        <li>
                                                            <p>Based on the workup, consider initiation of therapy with
                                                                SOMAVERT.</p>
                                                        </li>
                                                        <li>
                                                            <p>If the decision is to treat, LTs and clinical symptoms
                                                                should be monitored very closely.</p>
                                                        </li>
                                                    </ul>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                    <p>If a patient develops LT elevations, or any other signs or symptoms of liver
                                        dysfunction while receiving SOMAVERT, the following patient management is
                                        recommended (Table 2).</p>
                                    <p style="font-weight: bold; ">Table 2. Clinical Recommendations Based on Liver Test
                                        Results While on SOMAVERT</p>
                                    <table width="75%">
                                        <colgroup span="2">
                                            <col width="39%" />
                                            <col width="48%" />
                                        </colgroup>
                                        <thead>
                                            <tr>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                    <b>LT Levels and Clinical Signs/Symptoms</b></th>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                    <b>Recommendations</b></th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                    <p>Greater than or equal to 3 but less than 5 times ULN (without
                                                        signs/symptoms of hepatitis or other liver injury, or increase
                                                        in serum TBIL)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                    <ul>
                                                        <li>
                                                            <p>May continue therapy with SOMAVERT. However, monitor LTs
                                                                weekly to determine if further increases occur (see
                                                                below).</p>
                                                        </li>
                                                        <li>
                                                            <p>Perform a comprehensive hepatic workup to discern if an
                                                                alternative cause of liver dysfunction is present.</p>
                                                        </li>
                                                    </ul>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>At least 5 times ULN, or transaminase elevations at least 3 times
                                                        ULN associated with any increase in serum TBIL (with or without
                                                        signs/symptoms of hepatitis or other liver injury)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <ul>
                                                        <li>
                                                            <p>Discontinue SOMAVERT immediately.</p>
                                                        </li>
                                                        <li>
                                                            <p>Perform a comprehensive hepatic workup, including serial
                                                                LTs, to determine if and when serum levels return to
                                                                normal.</p>
                                                        </li>
                                                        <li>
                                                            <p>If LTs normalize (regardless of whether an alternative
                                                                cause of the liver dysfunction is discovered), consider
                                                                cautious re-initiation of therapy with SOMAVERT, with
                                                                frequent LT monitoring.</p>
                                                        </li>
                                                    </ul>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; border-left: solid; ">
                                                    <p>Signs or symptoms suggestive of hepatitis or other liver injury
                                                        (e.g., jaundice, bilirubinuria, fatigue, nausea, vomiting, right
                                                        upper quadrant pain, ascites, unexplained edema, easy
                                                        bruisability)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <ul>
                                                        <li>
                                                            <p>Immediately perform a comprehensive hepatic workup.</p>
                                                        </li>
                                                        <li>
                                                            <p>If liver injury is confirmed, SOMAVERT should be
                                                                discontinued.</p>
                                                        </li>
                                                    </ul>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="2c2ea51f-a645-463b-bbe6-f4bb4bb91a7b">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.3" />
                        </extension>
                        <title value="5.3Cross-Reactivity With GH Assays" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>SOMAVERT has significant structural similarity to growth hormone (GH) which
                                        causes it to cross-react in commercially available GH assays. Since serum
                                        concentrations of therapeutically effective doses of SOMAVERT are generally 100
                                        to 1000 times higher than the actual serum GH concentrations seen in patients
                                        with acromegaly, measurements of serum GH concentrations will appear falsely
                                        elevated. </p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="93244e9f-4733-4a6b-afcf-c6fea7471e77">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.4" />
                        </extension>
                        <title value="5.4Lipohypertrophy" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>There have been cases of lipohypertrophy in patients treated with SOMAVERT. In a
                                        double-blind, 12-week, placebo-controlled study, there was one case (1.3%) of
                                        injection site lipohypertrophy reported in a subject receiving 10 mg/day. The
                                        subject recovered while on treatment. Among two open-label trials (with a total
                                        of 147 patients), there were two subjects, both receiving 10 mg/day, who
                                        developed lipohypertrophy. One case recovered while on treatment, and one case
                                        resulted in a discontinuation of treatment. Injection sites should be rotated
                                        daily to help prevent lipohypertrophy (different area than the last injection).
                                    </p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="a81c536b-a9a6-4fbf-8867-73eb3751479f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S5.5" />
                        </extension>
                        <title value="5.5Systemic Hypersensitivity" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>In patients with systemic hypersensitivity reactions, caution and close
                                        monitoring should be exercised when re-initiating SOMAVERT therapy <i>[see <a
                                                href="#ID_RefS6.3">Adverse Reactions (6.2)</a>]</i>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="105d9db4-55a5-4d76-8e50-c3409609ef94">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S6" />
                    </extension>
                    <title value="6 ADVERSE REACTIONS" />
                    <code><coding><system value="http://loinc.org" /><code value="34084-4" /><display value="ADVERSE REACTIONS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p><b>Most common reported adverse reactions (&gt;6%) are infection, pain, nausea,
                                        diarrhea, abnormal liver tests, flu syndrome, injection site reaction. (</b><a
                                        href="#S6.3">6</a><b>)To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc.
                                        at 1-800-438-1985 or FDA at 1-800-FDA-1088 or <a
                                            href="http://www.fda.gov/medwatch">www.fda.gov/medwatch</a>.</b></p>
                            </div>
                            <div style="narrative">
                                <p>Clinically significant adverse reactions that appear in other section of the labeling
                                    include:</p>
                                <ul>
                                    <li>
                                        <p>Hypoglycemia Associated with GH Lowering in Patients with Diabetes Mellitus
                                            <i>[see <a href="#ID_RefS5.1">Warnings and Precautions (5.1)</a>]</i></p>
                                    </li>
                                    <li>
                                        <p>Liver Toxicity <i>[see <a href="#ID_RefS5.2">Warnings and Precautions
                                                    (5.2)</a>]</i></p>
                                    </li>
                                    <li>
                                        <p>Cross-Reactivity with GH Assays <i>[see <a href="#ID_RefS5.3">Warnings and
                                                    Precautions (5.3)</a>]</i></p>
                                    </li>
                                    <li>
                                        <p>Lipohypertrophy <i>[see <a href="#ID_RefS5.4">Warnings and Precautions
                                                    (5.4)</a>]</i></p>
                                    </li>
                                    <li>
                                        <p>Systemic Hypersensitivity <i>[see <a href="#ID_RefS5.5">Warnings and
                                                    Precautions (5.5)</a>]</i></p>
                                    </li>
                                </ul>
                                <p>Elevations of serum concentrations of ALT and AST greater than ten times the ULN were
                                    reported in two patients (0.8%) exposed to SOMAVERT in pre-approval clinical
                                    studies. One patient was rechallenged with SOMAVERT, and the recurrence of elevated
                                    transaminase levels suggested a probable causal relationship between administration
                                    of the drug and the elevation in liver enzymes. A liver biopsy performed on the
                                    second patient was consistent with chronic hepatitis of unknown etiology. In both
                                    patients, the transaminase elevations normalized after discontinuation of the drug.
                                </p>
                                <p>Elevations in ALT and AST levels were not associated with increased levels of TBIL
                                    and ALP, with the exception of two patients with minimal associated increases in ALP
                                    levels (i.e., less than 3 times ULN). The transaminase elevations did not appear to
                                    be related to the dose of SOMAVERT administered, generally occurred within 4 to 12
                                    weeks of initiation of therapy, and were not associated with any identifiable
                                    biochemical, phenotypic, or genetic predictors.</p>
                            </div>
                        </div>
                    </text>
                    <section id="3af1a2f4-d457-4d9a-80a2-0bd2216d8b5f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_36affecb-65e8-4946-a279-4bec5fc6f778" />
                        </extension>
                        <title value="6.1Clinical Trials Experience" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Because clinical trials are conducted under widely varying conditions, adverse
                                        reaction rates observed in the clinical trials of a drug cannot be directly
                                        compared to rates in the clinical trials of another drug and may not reflect the
                                        rates observed in practice.</p>
                                    <p>In a 12-week randomized, placebo-controlled, double-blind, fixed-dose study of
                                        SOMAVERT in subjects with acromegaly, 32 subjects received placebo and 80
                                        subjects received SOMAVERT once daily <i>[see <a href="#ID_RefS14">Clinical
                                                Studies (14)</a>]</i>. A total of 108 subjects (30 placebo, 78 SOMAVERT)
                                        completed 12 weeks of study treatment.</p>
                                    <p>Overall, eight patients with acromegaly (5.3%) withdrew from pre-marketing
                                        clinical studies because of adverse events, including two patients with marked
                                        transaminase elevations, one patient with lipohypertrophy at the injection
                                        sites, and one patient with substantial weight gain. Most adverse events did not
                                        appear to be dose-dependent. Table 3 shows the incidence of adverse events that
                                        were reported in at least two patients treated with SOMAVERT and at frequencies
                                        greater than placebo during the 12-week, placebo-controlled study.</p>
                                    <table width="75%">
                                        <caption>Table 2. Adverse Reactions in a 12-week Placebo-Controlled Study in
                                            Patients with Acromegaly<a href="#_RefID0ECWAI" name="foot-ref-_RefID0ECWAI"
                                                class="Sup">1</a></caption>
                                        <colgroup span="5">
                                            <col width="23%" />
                                            <col width="14%" />
                                            <col width="22%" />
                                            <col width="14%" />
                                            <col width="14%" />
                                        </colgroup>
                                        <thead>
                                            <tr>
                                                <th rowspan="2" valign="middle" align="left"
                                                    style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                    <b> </b></th>
                                                <th rowspan="2" valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                    <b>Placebo</b><br /><b>n=32</b></th>
                                                <th colspan="3" valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                    <b>SOMAVERT</b></th>
                                            </tr>
                                            <tr>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; "><b>10
                                                        mg/day</b><br /><b>n=26</b></th>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; "><b>15
                                                        mg/day</b><br /><b>n=26</b></th>
                                                <th valign="middle" align="center"
                                                    style="border-right: solid; border-bottom: solid; "><b>20
                                                        mg/day</b><br /><b>N=28</b></th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                    <p>Infection<a href="#_RefID0E4XAI" name="foot-ref-_RefID0E4XAI"
                                                            class="Sup">2</a></p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (6%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">6 (23%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Pain</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (6%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">4 (14%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Nausea</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">4 (14%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Diarrhea</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">4 (14%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Abnormal liver function tests</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">3 (12%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Flu syndrome</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">3 (12%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (7%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Injection site reaction</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">3 (11%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Dizziness</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (6%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Accidental injury</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Back pain</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Sinusitis</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (3%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Chest pain</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Peripheral edema</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">1 (4%)</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                    <p>Hypertension</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (8%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                            </tr>
                                            <tr>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; border-left: solid; ">
                                                    <p>Paresthesia</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (6%)</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">0</p>
                                                </td>
                                                <td
                                                    style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                    <p style="text-align: center; ">2 (7%)</p>
                                                </td>
                                            </tr>
                                        </tbody>
                                    </table>
                                    <p><sup><a name="_RefID0ECWAI" href="#foot-ref-_RefID0ECWAI">1</a></sup>Table
                                        includes only those events that were reported in at least 2 patients and at a
                                        higher incidence in patients treated with SOMAVERT than in patients treated with
                                        placebo.</p>
                                    <p><sup><a name="_RefID0E4XAI" href="#foot-ref-_RefID0E4XAI">2</a></sup>The 6 events
                                        coded as "infection" in the group treated with SOMAVERT 10 mg were reported as
                                        cold symptoms (3), upper respiratory infection (1), blister (1), and ear
                                        infection (1). The 2 events in the placebo group were reported as cold symptoms
                                        (1) and chest infection (1).</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="fb6937b6-bf52-4d10-ba3d-417d69e58411">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S6.3" />
                        </extension>
                        <title value="6.2Postmarketing Experience" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="text-decoration: underline; ">Adverse Reactions from Postmarketing
                                        Spontaneous Reports</p>
                                    <p>The following adverse reactions have been identified during post-approval use of
                                        SOMAVERT. Because these reactions are reported voluntarily from a population of
                                        uncertain size, it is not always possible to reliably estimate their frequency
                                        or establish a causal relationship to drug exposure.</p>
                                    <p>Systemic hypersensitivity reactions including anaphylactic reactions,
                                        laryngospasm, angioedema, generalized skin reactions (rash, erythema, pruritus,
                                        urticaria) have been reported in post-marketing use. Some patients required
                                        hospitalization. Symptoms did not re-occur in all patients after re-challenge
                                        <i>[see <a href="#ID_RefS5.5">Warnings and Precautions (5.5)</a>]</i>.</p>
                                </div>
                            </div>
                        </text>
                        <section id="5ae40874-a910-4416-aa9e-56f79215ff35">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_32a9aa1f-1dff-4ae0-8e7e-40f28efd00f1" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">Adverse Reactions from an Observational
                                            Study</p>
                                        <p>ACROSTUDY was an international observational registry that captured long term
                                            safety data in 2221 patients with acromegaly treated with SOMAVERT for a
                                            mean treatment duration of 8.5 years. Patients could also receive other
                                            therapy for acromegaly during the registry period. Treatment dose and
                                            schedule were at the discretion of each treating healthcare provider.
                                            Although safety monitoring as per the recommended schedule was mandatory,
                                            not all assessments were performed at all time points for every patient.
                                            Because of this, comparison of rates of adverse events to those in the
                                            original clinical trial is not appropriate. Of the 1327 patients who had a
                                            normal AST and ALT at baseline, 20 (1.5%) patients had elevated tests
                                            &gt;3-5 times ULN, and 22 (1.7%) patients had elevated tests &gt;5 times
                                            ULN. Lipohypertrophy was reported in 35 (1.6%) patients. Of the 1795
                                            patients who had a MRI reported at baseline and at least once during follow
                                            up in the study, MRI results showed that 128 (7.1%) were reported to have an
                                            increase, 310 (17.3%) were reported to have a decrease, 81 (4.5%) had both
                                            increase and decrease, and 1276 (71.1%) had no change.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                </section>
                <section id="c0fa843f-67a9-45d5-800e-85ae18df3d0a">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S7" />
                    </extension>
                    <title value="7 DRUG INTERACTIONS" />
                    <code><coding><system value="http://loinc.org" /><code value="34073-7" /><display value="DRUG INTERACTIONS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <ul>
                                    <li>
                                        <p><i>Insulin and/or Oral hypoglycemic Agents:</i> Patients with acromegaly and
                                            with diabetes mellitus may require careful monitoring and dose reductions of
                                            insulin and/or oral hypoglycemic agents. (<a href="#ID_RefS5.2">5.2</a>, <a
                                                href="#ID_RefS7.1">7.1</a>)</p>
                                    </li>
                                    <li>
                                        <p><i>Opioids:</i> Patients on opioids may need higher SOMAVERT doses to achieve
                                            appropriate IGF-1 suppression. (<a href="#ID_RefS7.2">7.2</a>)</p>
                                    </li>
                                </ul>
                            </div>
                        </div>
                    </text>
                    <section id="813f5f16-e1c6-4534-8cd6-a322200e872b">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S7.1" />
                        </extension>
                        <title value="7.1Insulin and/or Oral Hypoglycemic Agents" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>After initiation of SOMAVERT, patients with acromegaly and diabetes mellitus
                                        treated with insulin and/or oral hypoglycemic agents may require dose reductions
                                        of insulin and/or oral hypoglycemic agents <i>[see <a
                                                href="#ID_RefS5.1">Warnings and Precautions (5.1)</a>]</i>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="0dc7d963-5bda-4231-8c81-a67a71b65a03">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S7.2" />
                        </extension>
                        <title value="7.2Opioids" />
                        <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>In clinical studies, patients taking opioids often needed higher SOMAVERT doses
                                        to normalize IGF-1 concentrations compared with patients not receiving opioids.
                                        The mechanism of this interaction is not known.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="3ead2756-96ad-4753-b299-cadea94ead6e">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S8" />
                    </extension>
                    <title value="8 USE IN SPECIFIC POPULATIONS" />
                    <code><coding><system value="http://loinc.org" /><code value="43684-0" /><display value="USE IN SPECIFIC POPULATIONS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="highlight">
                                <p><i>Females and Males of Reproductive Potential:</i> Advise premenopausal females of
                                    the potential for an unintended pregnancy. (<a
                                        href="#ID_RefS8.3">8.3</a>)<br /><br /></p>
                            </div>
                        </div>
                    </text>
                    <section id="46e80477-6870-42a0-b81e-5c03b8c0ca6a">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.1" />
                        </extension>
                        <title value="8.1 Pregnancy" />
                        <code><coding><system value="http://loinc.org" /><code value="42228-7" /><display value="PREGNANCY SECTION" /></coding></code>
                        <section id="3b1869c0-298d-4939-98ea-572814d09ae6">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_d60a7be3-487a-4c4c-ae8e-a8cf5f9cffe1" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">Risk Summary</p>
                                        <p>Postmarketing reports of SOMAVERT use in pregnant women are insufficient to
                                            establish a drug-associated risk for major birth defects, miscarriage or
                                            adverse maternal or fetal outcomes. Acromegaly may improve during pregnancy
                                            <i>(see <a href="#ID_Refclinicalconsideration">Clinical
                                                    Considerations</a>)</i>. In animal reproduction studies,
                                            fetotoxicity was observed at a dose that was 6 times the maximum recommended
                                            human dose based on body surface area following subcutaneous administration
                                            of pegvisomant during organogenesis or during the preimplantation period
                                            <i>(see <a href="#ID_Refrefdata">Data</a>)</i>.</p>
                                        <p>The estimated background risk of major birth defects and miscarriage for the
                                            indicated population is unknown. In the U.S. general population, the
                                            estimated background risk of major birth defects and miscarriage in
                                            clinically recognized pregnancies is 2–4% and 15–20%, respectively.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="4a3269e5-eecf-4c98-867e-ce637510b128">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="CC" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">Clinical Considerations </p>
                                    </div>
                                </div>
                            </text>
                            <section id="770eb814-34ed-43a9-bb6b-544e58bfaf27">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2023-07-27" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_0c76ca23-7ad4-46cc-810d-55d85e95fd03" />
                                </extension>
                                <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="font-style: italic; ">Disease-associated maternal and/or
                                                embryofetal risk</p>
                                            <p>Published data from case reports, case series, and a small interventional
                                                study in pregnant women with acromegaly have demonstrated that
                                                acromegaly may improve or stabilize without treatment during pregnancy,
                                                particularly if acromegaly is treated before pregnancy. In rare cases,
                                                acromegaly may worsen during pregnancy. Since IGF-1 levels may change
                                                physiologically during pregnancy and interpreting IGF-1 and growth
                                                hormone levels in pregnant women with acromegaly may be unreliable,
                                                clinical monitoring is recommended.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                        <section id="bb5ed557-3102-4f80-a5e3-edb5f20d0c80">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="Data" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">Data</p>
                                    </div>
                                </div>
                            </text>
                            <section id="82ff2907-7225-419d-bc93-717420b37214">
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                    <valueDateTime value="2023-07-27" />
                                </extension>
                                <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                    <valueString value="ID_96cef2b4-e2db-483a-91fa-1ad6efee50f2" />
                                </extension>
                                <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                    <status value="additional" />
                                    <div xmlns="http://www.w3.org/1999/xhtml">
                                        <div style="narrative">
                                            <p style="font-style: italic; ">Animal Data</p>
                                            <p>The effects of pegvisomant on early embryonic development and
                                                embryo-fetal development were evaluated in two separate studies, which
                                                were conducted in pregnant rabbits with pegvisomant at subcutaneous
                                                doses of 1, 3, and 10 mg/kg/day. There was no evidence of teratogenic
                                                effects associated with pegvisomant administration during organogenesis.
                                                At the 10-mg/kg/day dose (6 times the maximum human therapeutic dose
                                                based on body surface area), a reproducible, slight increase in
                                                post-implantation loss was observed in both studies.</p>
                                        </div>
                                    </div>
                                </text>
                            </section>
                        </section>
                    </section>
                    <section id="c120036f-814f-4c8c-82c8-4e3f26b36969">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.2" />
                        </extension>
                        <title value="8.2Lactation" />
                        <code><coding><system value="http://loinc.org" /><code value="77290-5" /><display value="LACTATION SECTION" /></coding></code>
                        <section id="f1fc7987-a706-4b5c-8775-1303dbb9263f">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_ab950384-62d3-48dd-a7e4-d099b394a864" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="text-decoration: underline; ">Risk Summary</p>
                                        <p>Limited information from a case report in published literature reported that
                                            the level of pegvisomant in human milk was below the level of detection.
                                            There is no information available on the effects of the drug on the
                                            breastfed infant or the effects of the drug on milk production. The
                                            developmental and health benefits of breastfeeding should be considered
                                            along with the mother's clinical need for SOMAVERT and any potential adverse
                                            effects on the breastfed child from SOMAVERT or from the underlying maternal
                                            condition.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="1d9bdd47-705b-496c-937f-412f80da6ea8">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.3" />
                        </extension>
                        <title value="8.3Females and Males of Reproductive Potential" />
                        <code><coding><system value="http://loinc.org" /><code value="77291-3" /><display value="FEMALES &amp; MALES OF REPRODUCTIVE POTENTIAL SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Discuss the potential for unintended pregnancy with premenopausal women as the
                                        therapeutic benefits of a reduction in growth hormone (GH) levels and
                                        normalization of insulin-like growth factor 1 (IGF-1) concentration in
                                        acromegalic females treated with pegvisomant may lead to improved fertility.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="0a471926-1fe3-4d7f-9b70-2e48da3042b4">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.4" />
                        </extension>
                        <title value="8.4Pediatric Use" />
                        <code><coding><system value="http://loinc.org" /><code value="34081-0" /><display value="PEDIATRIC USE SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The safety and effectiveness of SOMAVERT in pediatric patients have not been
                                        established.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="ad6ff9c7-6ef2-49b4-8f4b-7596764cd903">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.5" />
                        </extension>
                        <title value="8.5Geriatric Use" />
                        <code><coding><system value="http://loinc.org" /><code value="34082-8" /><display value="GERIATRIC USE SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Clinical studies of SOMAVERT did not include sufficient numbers of patients aged
                                        65 and over to determine whether they respond differently from younger patients.
                                        In general, dose selection for an elderly patient should be cautious, usually
                                        starting at the low end of the dosing range, reflecting the greater frequency of
                                        decreased hepatic, renal, or cardiac function, and of concomitant disease or
                                        other drug therapy.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="e7d8968f-8a32-4800-aa68-933c799ec07f">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S8.6" />
                        </extension>
                        <title value="8.6Renal Impairment" />
                        <code><coding><system value="http://loinc.org" /><code value="88828-9" /><display value="RENAL IMPAIRMENT SUBSECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>SOMAVERT was not studied in patients with renal impairment and the safety and
                                        efficacy in these patients is not known. </p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="2c113961-a4f5-44a5-9407-0759c7b52334">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S10" />
                    </extension>
                    <title value="10 OVERDOSAGE" />
                    <code><coding><system value="http://loinc.org" /><code value="34088-5" /><display value="OVERDOSAGE SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>In one reported incident of acute overdose with SOMAVERT during pre-marketing
                                    clinical studies, a patient self-administered 80 mg/day (2.7 times the maximum
                                    recommended maintenance dosage) for seven days. The patient experienced a slight
                                    increase in fatigue, had no other complaints, and demonstrated no significant
                                    clinical laboratory abnormalities.</p>
                                <p>In cases of overdose, administration of SOMAVERT should be discontinued and not
                                    resumed until IGF-1 levels return to within or above the normal range.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="5d21541c-52d8-4bb0-b13f-bbb64a342301">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S11" />
                    </extension>
                    <title value="11 DESCRIPTION" />
                    <code><coding><system value="http://loinc.org" /><code value="34089-3" /><display value="DESCRIPTION SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>Pegvisomant is an analog of human growth hormone (GH) of recombinant DNA origin that
                                    acts as a GH receptor antagonist.</p>
                                <p>It contains 191 amino acid residues. The molecular weight of pegvisomant is 22 kDa.
                                    The molecular weight of the PEG portion of pegvisomant is approximately 5 kDa. The
                                    predominant molecular weights of pegvisomant are thus approximately 42, 47, and 52
                                    kDa. The schematic shows the amino acid sequence of the pegvisomant protein (PEG
                                    polymers are shown attached to the 5 most probable attachment sites). Pegvisomant is
                                    synthesized by a specific strain of <i>Escherichia coli</i> bacteria that has been
                                    genetically modified by the addition of a plasmid that carries a gene for GH
                                    receptor antagonist. </p>
                                <table width="100%">
                                    <colgroup span="1">
                                        <col width="100%" />
                                    </colgroup>
                                    <tbody>
                                        <tr>
                                            <td style="vertical-align: middle; "><img src="somavert-01.jpg"
                                                    alt="Chemical Structure" id="id2842"></img></td>
                                        </tr>
                                        <tr>
                                            <td style="vertical-align: middle; ">
                                                <p style="text-align: center; ">Stippled residues indicate PEG
                                                    attachment sites (Phe<sub>1</sub>, Lys<sub>38</sub>,
                                                    Lys<sub>41</sub>, Lys<sub>70</sub>, Lys<sub>115</sub>,
                                                    Lys<sub>120</sub>, Lys<sub>140</sub>, Lys<sub>145</sub>,
                                                    Lys<sub>158</sub>)</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>Shown below are the amino acid substitutions in pegvisomant, relative to human GH.
                                </p>
                                <table width="50%">
                                    <colgroup span="2">
                                        <col width="27%" />
                                        <col width="31%" />
                                    </colgroup>
                                    <thead>
                                        <tr>
                                            <th valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <b>hGH</b></th>
                                            <th valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                <b>Pegvisomant</b></th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">His<sub>18 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Asp<sub>18 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Ala<sub>21 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Asn<sub>21 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Gly<sub>120 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Lys<sub>120 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Arg<sub>167 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Asn<sub>167 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Lys<sub>168 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Ala<sub>168 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Asp<sub>171 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Ser<sub>171 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Lys<sub>172 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Arg<sub>172 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Glu<sub>174 </sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Ser<sub>174 </sub></p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; border-left: solid; ">
                                                <p style="text-align: center; ">Ile<sub>179</sub></p>
                                            </td>
                                            <td
                                                style="vertical-align: middle; border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">Thr<sub>179 </sub></p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>SOMAVERT (pegvisomant) for injection is a sterile, white lyophilized powder intended
                                    for subcutaneous injection after reconstitution. SOMAVERT is supplied in packages
                                    that include a single-dose prefilled syringe containing 1 mL of Sterile Water for
                                    Injection, USP, that is a sterile, nonpyrogenic preparation of water for injection
                                    that contains no bacteriostat, antimicrobial agent, or added buffer, to be used as a
                                    diluent. </p>
                                <p>SOMAVERT is available in single-dose sterile vials containing 10 mg, 15 mg, 20 mg, 25
                                    mg or 30 mg of pegvisomant. SOMAVERT 10 mg, 15 mg, and 20 mg vials also contain
                                    glycine (1.36 mg), mannitol (36 mg), sodium dihydrogen phosphate monohydrate (0.36
                                    mg), and sodium phosphate dibasic anhydrous (1.04 mg). After reconstitution with 1
                                    mL of Water for Injection, USP, the resulting concentration is 10 mg/mL, 15 mg/mL
                                    and 20 mg/mL, respectively, with a pH of 7.1 – 7.7.</p>
                                <p>SOMAVERT 25 mg vial also contains glycine (1.7 mg), mannitol (45 mg), sodium
                                    dihydrogen phosphate monohydrate (0.45 mg), and sodium phosphate dibasic anhydrous
                                    (1.3 mg). After reconstitution with 1 mL of Water for Injection, USP, the resulting
                                    concentration is 25 mg/mL with a pH of 7.1 – 7.7.</p>
                                <p>SOMAVERT 30 mg vial also contains glycine (2.04 mg), mannitol (54 mg), sodium
                                    dihydrogen phosphate monohydrate (0.54 mg), and sodium phosphate dibasic anhydrous
                                    (1.56 mg). After reconstitution with 1 mL of Water for Injection, USP, the resulting
                                    concentration is 30 mg/mL with a pH of 7.1 – 7.7.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="0cbfe6be-e931-4b84-a64f-6f8dae014a1e">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S12" />
                    </extension>
                    <title value="12 CLINICAL PHARMACOLOGY" />
                    <code><coding><system value="http://loinc.org" /><code value="34090-1" /><display value="CLINICAL PHARMACOLOGY SECTION" /></coding></code>
                    <section id="3aecefff-b054-43c7-9833-13239f3aada6">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.1" />
                        </extension>
                        <title value="12.1Mechanism of Action" />
                        <code><coding><system value="http://loinc.org" /><code value="43679-0" /><display value="MECHANISM OF ACTION SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Pegvisomant selectively binds to growth hormone (GH) receptors on cell surfaces,
                                        where it blocks the binding of endogenous GH, and thus interferes with GH signal
                                        transduction.</p>
                                    <p>Inhibition of GH action results in decreased serum concentrations of IGF-1, as
                                        well as other GH-responsive serum proteins such as free IGF-1, the acid-labile
                                        subunit of IGF-1 (ALS), and insulin-like growth factor binding protein-3
                                        (IGFBP-3).</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="19914027-8dfb-4711-8b02-25c29e184771">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.2" />
                        </extension>
                        <title value="12.2Pharmacodynamics" />
                        <code><coding><system value="http://loinc.org" /><code value="43681-6" /><display value="PHARMACODYNAMICS SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>Pegvisomant binds selectively to the GH receptor, and does not cross-react with
                                        19 other cytokine receptors tested, including prolactin. Pegvisomant leads to
                                        decreased serum concentrations of IGF-1, free IGF-1, ALS, and IGFBP-3 <i>[see <a
                                                href="#ID_RefFigure1">Clinical Studies (14, Figure 1)</a>]</i>.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                    <section id="0b1bdc20-ea2f-4298-b28f-04112ed5cbe8">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S12.3" />
                        </extension>
                        <title value="12.3Pharmacokinetics" />
                        <code><coding><system value="http://loinc.org" /><code value="43682-4" /><display value="PHARMACOKINETICS SECTION" /></coding></code>
                        <section id="6fbbc3a7-27e4-4f9e-87b2-f040853c8175">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_1690d7f3-bbcf-4769-86f9-f240a93eaf84" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p><i>Absorption:</i> Following subcutaneous administration, peak serum
                                            pegvisomant concentrations are not generally attained until 33 to 77 hours
                                            after administration. The mean extent of absorption of a 20-mg subcutaneous
                                            dose was 57%, relative to a 10-mg intravenous dose.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="02755621-477d-4009-b102-d6e0f8656870">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_746cdd5e-187c-4983-afbf-ee6d2bfe37c3" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p><i>Distribution:</i> The mean apparent volume of distribution of pegvisomant
                                            is 7 L (12% coefficient of variation), suggesting that pegvisomant does not
                                            distribute extensively into tissues. After a single subcutaneous
                                            administration, exposure (C<sub>max</sub>, AUC) to pegvisomant increases
                                            disproportionately with increasing dose. Mean ± SEM serum pegvisomant
                                            concentrations after 12 weeks of therapy with daily doses of 10, 15, and 20
                                            mg were 6600 ± 1330; 16,000 ± 2200; and 27,000 ± 3100 ng/mL, respectively.
                                        </p>
                                        <p>The relative bioavailability of 1 × 30 mg pegvisomant was compared to 2 × 15
                                            mg pegvisomant in a single-dose study. The AUC<sub>inf</sub> and
                                            C<sub>max</sub> of pegvisomant when administered as one injection of 30 mg
                                            strength was approximately 6% and 4% greater, respectively, as compared to
                                            when administered as two injections of 15 mg strengths.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="cd8bc600-800a-42fb-943e-fdb269cb8f3a">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_26a7ff14-d738-45fc-bbea-f5675cc2dfb1" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p><i>Metabolism and Elimination:</i> The pegvisomant molecule contains
                                            covalently bound polyethylene glycol polymers in order to reduce the
                                            clearance rate. Clearance of pegvisomant following multiple doses is lower
                                            than seen following a single-dose. The mean total body systemic clearance of
                                            pegvisomant following multiple doses is estimated to range between 36 to 28
                                            mL/h for subcutaneous doses ranging from 10 to 20 mg/day, respectively.
                                            Clearance of pegvisomant was found to increase with body weight. Pegvisomant
                                            is eliminated from serum with a mean half-life estimates ranging from 60 to
                                            138 hours following either single or multiple doses. Less than 1% of
                                            administered drug is recovered in the urine over 96 hours. The elimination
                                            route of pegvisomant has not been studied in humans.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="846eaed7-8f17-45c7-85c2-46ba45e8e8bc">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_6ece6819-d438-41c4-b8f1-e56b5fc93144" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="font-weight: bold; ">Drug Interaction Studies</p>
                                        <p>In clinical studies, patients on opioids often needed higher serum
                                            pegvisomant concentrations to achieve appropriate IGF-1 suppression compared
                                            with patients not receiving opioids. The mechanism of this interaction is
                                            not known <i>[see <a href="#ID_RefS7.2">Drug Interactions (7.2)</a>]</i>.
                                        </p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="d33d3ddf-2d48-431f-8c70-dea83dd7c6cd">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_a3214fc9-8901-4b94-8992-28931884e802" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="font-weight: bold; ">Specific Populations</p>
                                        <p>No pharmacokinetic studies have been conducted in patients with renal
                                            impairment, patients with hepatic impairment, geriatric patients, or
                                            pediatric patients and the effects of race on the pharmacokinetics of
                                            pegvisomant has not been studied. No gender effect on the pharmacokinetics
                                            of pegvisomant was found in a population pharmacokinetic analysis.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                    <section id="3f194bdf-4399-4ab1-b9c1-8a30da27c3eb">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_d1b3367f-ad04-4513-8f20-595b027ce519" />
                        </extension>
                        <title value="12.6Immunogenicity" />
                        <code><coding><system value="http://loinc.org" /><code value="88830-5" /><display value="IMMUNOGENICITY" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p>The observed incidence of anti-drug antibodies is highly dependent on the
                                        sensitivity and specificity of the assay. Differences in assay methods preclude
                                        meaningful comparisons of the incidence of anti-drug antibodies in the studies
                                        described below with the incidence of anti-drug antibodies in other studies,
                                        including those of SOMAVERT or other growth hormone analogs.</p>
                                    <p>In pre-marketing clinical studies, approximately 17% of the SOMAVERT-treated
                                        patients developed low titer, non‑neutralizing anti-GH antibodies. Although the
                                        presence of these antibodies did not appear to impact the efficacy of SOMAVERT,
                                        the long term clinical significance of these antibodies is not known. No assay
                                        for anti-pegvisomant antibodies is commercially available for patients receiving
                                        SOMAVERT.</p>
                                    <p>The data above reflect the percentage of patients whose test results were
                                        considered positive for antibodies to SOMAVERT. The detection of antibody
                                        formation is highly dependent on the sensitivity and specificity of the assay.
                                        Additionally, the observed incidence of antibody positivity in an assay may be
                                        influenced by several factors including sample handling, timing of sample
                                        collection, concomitant medications, and underlying disease. For these reasons,
                                        comparison of the incidence of antibodies to SOMAVERT with the incidence of
                                        antibodies to other products may be misleading.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="84c80644-76a9-4d46-a7c8-fafeefa97c43">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S13" />
                    </extension>
                    <title value="13 NONCLINICAL TOXICOLOGY" />
                    <code><coding><system value="http://loinc.org" /><code value="43680-8" /><display value="NONCLINICAL TOXICOLOGY SECTION" /></coding></code>
                    <section id="8179c5d0-fb24-493e-898d-121c3f469b7b">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="S13.1" />
                        </extension>
                        <title value="13.1Carcinogenesis, Mutagenesis, Impairment of Fertility" />
                        <code><coding><system value="http://loinc.org" /><code value="34083-6" /><display value="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION" /></coding></code>
                        <section id="6d2fb5b6-f6b1-46fc-a3a6-d41665722f78">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_2dfce465-2002-4328-b92e-e118296d1f72" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="font-style: italic; ">Carcinogenesis</p>
                                        <p>Pegvisomant was administered subcutaneously to rats daily for 2 years at
                                            doses of 2, 8, and 20 mg/kg (about 2, 9, and 22-fold a single 30 mg dose in
                                            humans on an AUC basis). Long term treatment with pegvisomant at 8 and 20
                                            mg/kg caused an increase in malignant fibrous histiocytoma at injection
                                            sites in males. Injection site tumors were not seen in female rats at the
                                            same doses. The increased incidence of injection site tumors was most
                                            probably caused by irritation and the high sensitivity of the rat to
                                            repeated subcutaneous injections.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="1a87ce8a-e6f6-4014-8af8-39deb5a3e0f0">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_e58dd6e2-7d6a-4f6a-bf31-f66ada1542ef" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="font-style: italic; ">Mutagenesis</p>
                                        <p>Pegvisomant did not cause genetic damage in standard <i>in vitro</i> assays
                                            (bacterial mutation, human lymphocyte chromosome aberration).</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                        <section id="18023bae-6842-4714-ba44-11833cf249fa">
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                                <valueDateTime value="2023-07-27" />
                            </extension>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                                <valueString value="ID_564cd49a-701d-4622-8194-5ab3076fee11" />
                            </extension>
                            <code><coding><system value="http://loinc.org" /><code value="42229-5" /><display value="SPL UNCLASSIFIED SECTION" /></coding></code><text>
                                <status value="additional" />
                                <div xmlns="http://www.w3.org/1999/xhtml">
                                    <div style="narrative">
                                        <p style="font-style: italic; ">Impairment of Fertility </p>
                                        <p>Fertility studies have not been conducted with pegvisomant.</p>
                                    </div>
                                </div>
                            </text>
                        </section>
                    </section>
                </section>
                <section id="4626db46-b58e-4121-aa85-dce187e1f927">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S14" />
                    </extension>
                    <title value="14 CLINICAL STUDIES" />
                    <code><coding><system value="http://loinc.org" /><code value="34092-7" /><display value="CLINICAL STUDIES SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>A total of one hundred twelve patients (63 men and 49 women) with acromegaly
                                    participated in a 12-week, randomized, double-blind, multi-center study comparing
                                    placebo and SOMAVERT. The mean ±SD age was 48±14 years, and the mean duration of
                                    acromegaly was 8±8 years. Ninety three had undergone previous pituitary surgery, of
                                    which 57 had also been treated with conventional radiation therapy. Six patients had
                                    undergone irradiation without surgery, nine had received only drug therapy, and four
                                    had received no previous therapy. At study start, the mean ± SD time since the
                                    subjects' last surgery and/or irradiation therapy, respectively, was 6.8 ± 0.93
                                    years (n=63) and 5.6 ± 0.57 years (n=93).</p>
                                <p>Subjects were qualified for enrollment if their serum IGF-1, drawn after the required
                                    drug washout period, was ≥1.3 times the upper limit of the age-adjusted normal
                                    range. They were randomly assigned at the baseline visit to one of four treatment
                                    groups: placebo (n=32), 10 mg/day (n=26), 15 mg/day (n= 26), or 20 mg/day (n=28) of
                                    SOMAVERT subcutaneously IGF-1. The primary efficacy endpoint was IGF-1 percent
                                    change in IGF-1 concentrations from baseline to week 12. The three groups that
                                    received SOMAVERT showed statistically significant (p&lt;0.01) reductions in serum
                                    levels of IGF-1 compared with the placebo group (Table 4).</p>
                                <table width="76.48%">
                                    <caption>Table 3. Mean Percent Change from Baseline in IGF-1 at Week 12 for
                                        Intent-to-Treat Population</caption>
                                    <colgroup span="5">
                                        <col width="21%" />
                                        <col width="15%" />
                                        <col width="21%" />
                                        <col width="15%" />
                                        <col width="15%" />
                                    </colgroup>
                                    <thead>
                                        <tr>
                                            <th rowspan="2" valign="top" align="left"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; " />
                                            <th rowspan="2" valign="top" align="center"
                                                style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                <b>Placebo</b><br /><b>n=31</b></th>
                                            <th colspan="3" valign="top" align="center"
                                                style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                <b>SOMAVERT</b></th>
                                        </tr>
                                        <tr>
                                            <th valign="top" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>10
                                                    mg/day</b><br /><b>n=26</b></th>
                                            <th valign="top" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>15
                                                    mg/day</b><br /><b>n=26</b></th>
                                            <th valign="top" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>20
                                                    mg/day</b><br /><b>n=28</b></th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Mean baseline IGF-1
                                                    (ng/ml) (SD)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">670 (288)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">627 (251)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">649 (293)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">732 (205)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Mean percent change
                                                    from baseline in IGF-1 (SD)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">-4.0 (17)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">-27 (28)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">-48 (26)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">-63 (21)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-bottom: solid; border-left: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">SOMAVERT minus
                                                    Placebo<br />(95% CI for treatment difference)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; " />
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; "><b>-23</b><a href="#_Reft4f1"
                                                        name="foot-ref-_Reft4f1" class="Sup">1</a><br /><b>(-35,
                                                        -11)</b></p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; "><b>-44</b><a href="#_Reft4f1"
                                                        name="foot-ref-_Reft4f1" class="Sup">1</a><br /><b>(-56,
                                                        -33)</b></p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; "><b>-59</b><a href="#_Reft4f1"
                                                        name="foot-ref-_Reft4f1" class="Sup">1</a><br /><b>(-68,
                                                        -49)</b></p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p><sup><a name="_Reft4f1" href="#foot-ref-_Reft4f1">1</a></sup>P&lt;0.01; n=number of
                                    patients; SD = standard deviation</p>
                                <p>There were also reductions in serum levels of free IGF-1, IGFBP-3, and ALS compared
                                    with placebo at all post-baseline visits (Figure 1).</p>
                                <p style="font-weight: bold; ">Figure 1. Effects of SOMAVERT on Serum Markers (Mean ±
                                    Standard Error)</p>
                                <table width="100%">
                                    <colgroup span="1">
                                        <col width="100%" />
                                    </colgroup>
                                    <tbody>
                                        <tr>
                                            <td style="vertical-align: middle; "><img src="somavert-02.jpg"
                                                    alt="Figure 1" id="id3123"></img></td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>After 12 weeks of treatment, the following percentages of patients had normalized
                                    IGF-1 (Figure 2):</p>
                                <p style="font-weight: bold; ">Figure 2. Percent of Patients Whose IGF-1 Levels
                                    Normalized at Week 12</p>
                                <table width="100%">
                                    <colgroup span="1">
                                        <col width="100%" />
                                    </colgroup>
                                    <tbody>
                                        <tr>
                                            <td style="vertical-align: middle; "><img src="somavert-03.jpg"
                                                    alt="Figure 2" id="id3131"></img></td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>Table 5 shows the effect of treatment with SOMAVERT on ring size (standard jeweler's
                                    sizes converted to a numeric score ranging from 1 to 63), and on signs and symptoms
                                    of acromegaly. Each individual score for a sign or symptom of acromegaly (for
                                    soft-tissue swelling, arthralgia, headache, perspiration and fatigue) was based on a
                                    nine-point ordinal rating scale (0 = absent and 8 = severe and incapacitating), and
                                    the total score for signs or symptoms of acromegaly was derived from the sum of the
                                    individual scores. Mean baseline scores were as follows: ring size = 47.1; total
                                    signs and symptoms = 15.2; soft tissue swelling = 2.5; arthralgia = 3.2; headache =
                                    2.4; perspiration = 3.3; and fatigue = 3.7.</p>
                                <table width="77.2%">
                                    <caption>Table 4. Mean Change from Baseline (SD) at Week 12 for Ring Size and Signs
                                        and Symptoms of Acromegaly</caption>
                                    <colgroup span="5">
                                        <col width="22%" />
                                        <col width="15%" />
                                        <col width="21%" />
                                        <col width="15%" />
                                        <col width="15%" />
                                    </colgroup>
                                    <thead>
                                        <tr>
                                            <th rowspan="2" valign="top" align="left"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; " />
                                            <th rowspan="2" valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                <b>Placebo</b><br /><b>n=30</b></th>
                                            <th colspan="3" valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; border-top: solid; ">
                                                <b>SOMAVERT</b></th>
                                        </tr>
                                        <tr>
                                            <th valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>10
                                                    mg/day</b><br /><b>n=26</b></th>
                                            <th valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>15
                                                    mg/day</b><br /><b>n=24–25</b></th>
                                            <th valign="middle" align="center"
                                                style="border-right: solid; border-bottom: solid; "><b>20
                                                    mg/day</b><br /><b>n=26–27</b></th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>Ring size</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.1 (2.3)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.8 (1.6)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.9 (2.0)</p>
                                            </td>
                                            <td style="border-right: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-2.5 (3.3)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>Total score for signs and symptoms of acromegaly</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">1.3 (6.0)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-2.5 (4.3)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-4.4 (5.9)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-4.7 (4.7)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>  Soft-tissue swelling</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">0.3 (2.3)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.7 (1.6)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.2 (2.3)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.3 (1.3)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>  Arthralgia</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">0.1 (1.8)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.3 (1.8)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.5 (2.5)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.4 (2.1)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>  Headache</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">0.1 (1.7)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.4 (1.6)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.3 (1.4)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.3 (2.0)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>  Perspiration</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">0.1 (1.7)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.6 (1.6)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.1 (1.3)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.7 (1.6)</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-bottom: solid; border-left: solid; ">
                                                <p>  Fatigue</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">0.7 (1.5)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-0.5 (1.4)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.3 (1.7)</p>
                                            </td>
                                            <td style="border-right: solid; border-bottom: solid; ">
                                                <p style="text-align: center; ">-1.0 (1.6)</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>Serum growth hormone (GH) concentrations, as measured by research assays using
                                    antibodies that do not cross-react with pegvisomant, rose within two weeks of
                                    beginning treatment with SOMAVERT. The largest increase in GH concentration was seen
                                    in patients treated with doses of SOMAVERT 20 mg/day. This effect is presumably the
                                    result of diminished inhibition of GH secretion as IGF-1 levels fall. As shown in
                                    Figure 3, when patients with acromegaly were given a loading dose of SOMAVERT
                                    followed by a fixed daily dose, the rise in GH was inversely proportional to the
                                    fall in IGF-1 and generally stabilized by week 2. Serum GH concentrations remained
                                    stable in patients treated with SOMAVERT for the average of 43 weeks (range, 0–82
                                    weeks).</p>
                                <p style="font-weight: bold; ">Figure 3. Percent Change in Serum GH and IGF-1
                                    Concentrations</p>
                                <table width="100%">
                                    <colgroup span="1">
                                        <col width="100%" />
                                    </colgroup>
                                    <tbody>
                                        <tr>
                                            <td style="vertical-align: middle; "><img src="somavert-04.jpg"
                                                    alt="Figure 3" id="id3203"></img></td>
                                        </tr>
                                    </tbody>
                                </table>
                                <p>In the open-label extension to the clinical study, 109 subjects (including 6 new
                                    patients) with mean treatment exposure of 42.6 weeks (range 1 day – 82 weeks), 93
                                    (85.3%) subjects had an adverse event, 16 (14.7%) had an SAE, and 4 (3.7%)
                                    discontinued due to an AE (headaches, elevated liver function tests, pancreatic
                                    cancer, and weight gain). A total of 100 (92.6%) of the 108 subjects with available
                                    IGF-1 data had a normal IGF-1 concentration at any visit during the study.</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="73585ce6-bf8a-41cf-ae20-bd6e11fb6108">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S16" />
                    </extension>
                    <title value="16 HOW SUPPLIED/STORAGE AND HANDLING" />
                    <code><coding><system value="http://loinc.org" /><code value="34069-5" /><display value="HOW SUPPLIED SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>SOMAVERT (pegvisomant) for injection is a white lyophilized powder supplied in the
                                    following strengths and package configurations:</p>
                                <table width="75%">
                                    <colgroup span="3">
                                        <col width="18%" />
                                        <col width="32%" />
                                        <col width="37%" />
                                    </colgroup>
                                    <tbody>
                                        <tr style="border-top: solid ">
                                            <td colspan="3"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p style="font-weight: bold; ">One Day Package Configuration</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Strength</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">NDC</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Description</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>10 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7166-01</p>
                                            </td>
                                            <td rowspan="5"
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>One single-dose vial with one prefilled syringe containing 1 mL of
                                                    diluent (Sterile Water for Injection, USP) and a separate 27 -gauge
                                                    ½ inch safety needle per carton</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>15 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7168-01</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>20 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7188-01</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>25 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7199-01</p>
                                            </td>
                                        </tr>
                                        <tr style="border-bottom: solid ">
                                            <td
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p>30 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p>0009-7200-01</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                                <table width="75%">
                                    <colgroup span="3">
                                        <col width="18%" />
                                        <col width="32%" />
                                        <col width="37%" />
                                    </colgroup>
                                    <tbody>
                                        <tr style="border-top: solid ">
                                            <td colspan="3"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p style="font-weight: bold; ">30-Day Package Configuration</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Strength</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">NDC</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; text-align: center; ">Description</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>10 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7166-30</p>
                                            </td>
                                            <td rowspan="5"
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>Each outer carton contains three intermediate cartons, 30 prefilled
                                                    syringes containing 1 mL of diluent (Sterile Water for Injection,
                                                    USP), and 30 separate 27-gauge ½ inch safety needles. Each
                                                    intermediate carton contains ten single-dose vials of Somavert. </p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>15 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7168-30</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>20 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7188-30</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>25 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-left: solid; border-top: solid; border-bottom: solid; ">
                                                <p>0009-7199-30</p>
                                            </td>
                                        </tr>
                                        <tr style="border-bottom: solid ">
                                            <td
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p>30 mg per vial</p>
                                            </td>
                                            <td
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p>0009-7200-30</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </text>
                    <section id="52121585-43f8-45b0-a82d-3e6cbfdcab5e">
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                            <valueDateTime value="2023-07-27" />
                        </extension>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                            <valueString value="ID_f5276652-87b5-44fd-b476-ccb023745e97" />
                        </extension>
                        <code><coding><system value="http://loinc.org" /><code value="44425-7" /><display value="STORAGE AND HANDLING SECTION" /></coding></code><text>
                            <status value="additional" />
                            <div xmlns="http://www.w3.org/1999/xhtml">
                                <div style="narrative">
                                    <p style="font-weight: bold; ">Storage</p>
                                    <p>Prior to reconstitution:</p>
                                    <ul>
                                        <li>
                                            <p>The One Day Package of SOMAVERT should be stored in a refrigerator at 2°C
                                                to 8°C (36°F to 46°F).</p>
                                        </li>
                                        <li>
                                            <p>For the 30-Day Package, remove the three intermediate cartons containing
                                                the SOMAVERT vials and store in a refrigerator at 2°C to 8°C (36°F to
                                                46°F).</p>
                                        </li>
                                        <li>
                                            <p>For convenience, the One Day Package and intermediate cartons in the
                                                30-Day Package containing the SOMAVERT vial(s), may be stored at room
                                                temperature up to 25°C (77°F) for a single period of up to 30 days. </p>
                                            <ul>
                                                <li>
                                                    <p>In the space provided on the carton, record the date when the
                                                        carton was removed from the refrigerator and the discard date
                                                        (30 days after removal from the refrigerator).</p>
                                                </li>
                                                <li>
                                                    <p>Once the carton has been stored at room temperature, it should
                                                        not be placed back into the refrigerator. If not used within 30
                                                        days at room temperature, the vial(s) should be discarded.</p>
                                                </li>
                                            </ul>
                                        </li>
                                    </ul>
                                    <p>Discard the SOMAVERT vial(s) after the expiration date printed on the carton or
                                        the discard date, whichever is sooner.</p>
                                    <p>The prefilled syringe(s) may be stored at a temperature up to 30°C (86°F) until
                                        the expiration date printed on the carton, at which point they should be
                                        discarded. </p>
                                    <p>Do not freeze.</p>
                                </div>
                            </div>
                        </text>
                    </section>
                </section>
                <section id="7dcae6c0-6184-4990-bfc0-c60eb46dd1c0">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="S17" />
                    </extension>
                    <title value="17 PATIENT COUNSELING INFORMATION" />
                    <code><coding><system value="http://loinc.org" /><code value="34076-0" /><display value="INFORMATION FOR PATIENTS SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>Advise the patient to read the FDA-approved patient labeling (Patient Information and
                                    Instructions for Use).</p>
                                <p>Inform patients (and/or their caregivers) of the following information to aid in the
                                    safe and effective use of SOMAVERT:</p>
                                <ul>
                                    <li>
                                        <p>Not to use SOMAVERT if they are allergic to SOMAVERT or anything in it.</p>
                                    </li>
                                    <li>
                                        <p>They will need blood testing to check IGF-1 levels and liver tests before and
                                            during treatment with SOMAVERT and that the dose of SOMAVERT may be changed
                                            based on the results of these tests.</p>
                                    </li>
                                    <li>
                                        <p>SOMAVERT has not been studied in pregnant women and instruct them to notify
                                            their healthcare provider as soon as they are aware that they are pregnant.
                                        </p>
                                    </li>
                                    <li>
                                        <p>It is not known whether SOMAVERT is excreted in human milk and instruct them
                                            to notify their healthcare provider if they plan to do so.</p>
                                    </li>
                                    <li>
                                        <p>Pregnancy: Inform female patients that treatment with SOMAVERT may result in
                                            unintended pregnancy <i>[see <a href="#ID_RefS8.3">Females and Males of
                                                    Reproductive Potential (8.3)</a>].</i></p>
                                    </li>
                                </ul>
                                <p>Advise patients (and/or their caregivers) of the following adverse reactions:</p>
                                <ul>
                                    <li>
                                        <p>The most common reported adverse reactions are injection site reaction,
                                            elevations of liver tests, pain, nausea, and diarrhea.</p>
                                    </li>
                                    <li>
                                        <p>If they have liver test elevations they may need to have more frequent liver
                                            tests and/or discontinue SOMAVERT. Instruct patients to immediately
                                            discontinue therapy and contact their physician if they become jaundiced.
                                        </p>
                                    </li>
                                    <li>
                                        <p>GH-secreting tumors may enlarge in people with acromegaly and that these
                                            tumors need to be watched carefully and monitored by MRI imaging.</p>
                                    </li>
                                    <li>
                                        <p>Thickening under the skin may occur at the injection site that could lead to
                                            lumps and that switching sites may prevent or lessen this.</p>
                                    </li>
                                    <li>
                                        <p>If they have diabetes mellitus, they may require careful monitoring and dose
                                            reductions of insulin and/or oral hypoglycemic agents while on SOMAVERT.</p>
                                    </li>
                                    <li>
                                        <p>If they take opioids, they may need higher SOMAVERT doses to achieve
                                            appropriate IGF-1 suppression.</p>
                                    </li>
                                </ul>
                                <p>Inform patients (and/or their caregivers) about the storage options prior to
                                    reconstitution of the product <i>[see <a href="#ID_RefS16">How Supplied/Storage and
                                            Handling (16)</a>]</i>.</p>
                                <p>Advise patients to follow the directions for reconstitution provided in the
                                    Instructions for Use. Include that spraying the diluent directly onto the powder may
                                    cause foaming and that shaking may induce denaturation (destruction) of the active
                                    ingredient (therefore <b>do not shake</b>).</p><img src="somavert-05.jpg" alt="Logo"
                                    id="id3341"></img>
                                <p>U.S. License No. 1216</p>
                                <p>This product's labeling may have been updated. For the most recent prescribing
                                    information, please visit <a href="https://www.pfizer.com/">www.pfizer.com</a>.</p>
                                <p>LAB-0782-4.0</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="904af9fa-b860-4e82-bc55-3c62b194142d">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="PI" />
                    </extension>
                    <code><coding><system value="http://loinc.org" /><code value="42230-3" /><display value="SPL PATIENT PACKAGE INSERT SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <table width="100%">
                                    <colgroup span="3">
                                        <col width="6%" />
                                        <col width="47%" />
                                        <col width="47%" />
                                    </colgroup>
                                    <tfoot>
                                        <tr>
                                            <td align="left" valign="top" style="border-bottom: solid" colspan="3">This
                                                Patient Information has been approved by the U.S. Food and Drug
                                                Administration.     Revised: 7/2023</td>
                                        </tr>
                                    </tfoot>
                                    <tbody>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; border-top: solid; ">
                                                <p style="text-align: center; ">PATIENT INFORMATION<br />SOMAVERT
                                                    (SOM-ah-vert)<br />(pegvisomant)<br />for injection, for
                                                    subcutaneous use</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p><b>What is SOMAVERT?</b><br />SOMAVERT is a prescription medicine
                                                    used to treat people who have too much growth hormone (acromegaly).
                                                    SOMAVERT is used to treat people who are not able to be treated or
                                                    have not already been helped by surgery or radiation.<br />It is not
                                                    known if SOMAVERT is safe and effective in children.</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; ">Before you use SOMAVERT, tell your
                                                    healthcare provider about all of your medical conditions, including
                                                    if you:</p>
                                                <ul>
                                                    <li>
                                                        <p>are allergic to pegvisomant or any of the ingredients in
                                                            SOMAVERT. <b>Do not take SOMAVERT if you are allergic to
                                                                pegvisomant or any of the ingredients in SOMAVERT</b>.
                                                            See the end of this Patient Information leaflet for a
                                                            complete list of ingredients in SOMAVERT.</p>
                                                    </li>
                                                    <li>
                                                        <p>have diabetes.</p>
                                                    </li>
                                                    <li>
                                                        <p>have or have had liver problems.</p>
                                                    </li>
                                                    <li>
                                                        <p>are pregnant or plan to become pregnant. It is not known if
                                                            SOMAVERT will harm your unborn baby. Tell your healthcare
                                                            provider if you become pregnant while using SOMAVERT.</p>
                                                    </li>
                                                    <li>
                                                        <p>are breastfeeding or plan to breastfeed. It is not known if
                                                            SOMAVERT passes into your breast milk. You and your
                                                            healthcare provider should decide how you will feed your
                                                            baby if you take SOMAVERT.</p>
                                                    </li>
                                                </ul>
                                                <p><b>Tell your healthcare provider about all the medicines you
                                                        take</b>, including prescription and over-the-counter medicines,
                                                    vitamins, and herbal supplements.<br />SOMAVERT may affect the way
                                                    other medicines work, and other medicines may affect how SOMAVERT
                                                    works. <br />Especially tell your healthcare provider if you take:
                                                </p>
                                                <ul>
                                                    <li>
                                                        <p>insulin or other medicines used to treat diabetes. </p>
                                                    </li>
                                                    <li>
                                                        <p>narcotics (opioid medicines). Your healthcare provider may
                                                            change your dose of SOMAVERT if you take opioids.</p>
                                                    </li>
                                                </ul>
                                                <p>If you are not sure, ask your healthcare provider or pharmacist
                                                    whether you take these medicines. </p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; ">How should I use SOMAVERT?</p>
                                                <ul>
                                                    <li>
                                                        <p>Read the <b>Instructions for Use</b> at the end of this
                                                            Patient Information for information about the right way to
                                                            use SOMAVERT. </p>
                                                    </li>
                                                    <li>
                                                        <p>Your healthcare provider should do blood tests to check your
                                                            liver and insulin-like growth factor-1 (IGF-1) levels before
                                                            you start and while you use SOMAVERT. Your healthcare
                                                            provider may need to change your dose of SOMAVERT. </p>
                                                    </li>
                                                    <li>
                                                        <p>SOMAVERT is given 1 time each day as an injection under your
                                                            skin (subcutaneous). Some people may need to give 2
                                                            injections for their dose each day. Your healthcare provider
                                                            will tell you if you need to give 2 injections for your
                                                            dose.</p>
                                                    </li>
                                                    <li>
                                                        <p>Your first injection of SOMAVERT should be given by your
                                                            healthcare provider.</p>
                                                    </li>
                                                    <li>
                                                        <p>Your healthcare provider will teach you or your caregiver how
                                                            to use SOMAVERT.</p>
                                                    </li>
                                                    <li>
                                                        <p>If you use too much SOMAVERT, call your healthcare provider
                                                            right away. </p>
                                                    </li>
                                                    <li>
                                                        <p>If you miss a dose of SOMAVERT, just take the next dose at
                                                            the regular time. Do <b>not</b> take 2 doses at the same
                                                            time. If you are not sure about your dosing, ask your
                                                            healthcare provider.</p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3" style="border-right: solid; border-left: solid; ">
                                                <p style="font-weight: bold; ">What are the possible side effects of
                                                    SOMAVERT?<br />SOMAVERT may cause serious side effects, including:
                                                </p>
                                                <ul>
                                                    <li>
                                                        <p><b>changes in your blood sugar leve</b>l. Your healthcare
                                                            provider may change your dose of diabetes medicine while you
                                                            take SOMAVERT. </p>
                                                    </li>
                                                    <li>
                                                        <p><b>liver problems</b>. Stop injecting SOMAVERT right away and
                                                            call your healthcare provider if you have any of the
                                                            following symptoms of liver problems: </p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-left: solid; " />
                                            <td>
                                                <ul>
                                                    <li>
                                                        <p>yellowing of your eyes (jaundice)</p>
                                                    </li>
                                                    <li>
                                                        <p>dark, amber-colored urine</p>
                                                    </li>
                                                    <li>
                                                        <p>feeling very tired (fatigue or exhaustion)</p>
                                                    </li>
                                                    <li>
                                                        <p>nausea and vomiting</p>
                                                    </li>
                                                </ul>
                                            </td>
                                            <td style="border-right: solid; ">
                                                <ul>
                                                    <li>
                                                        <p>pain in your stomach (abdomen)</p>
                                                    </li>
                                                    <li>
                                                        <p>generalized swelling</p>
                                                    </li>
                                                    <li>
                                                        <p>bruising easily </p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3" style="border-right: solid; border-left: solid; ">
                                                <ul>
                                                    <li>
                                                        <p><b>skin thickening at your injection site that could lead to
                                                                lumps (lipohypertrophy</b>)</p>
                                                    </li>
                                                    <li>
                                                        <p><b>allergic reactions</b>. Call your healthcare provider
                                                            right away if you have any of the following symptoms of a
                                                            serious allergic reaction:</p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-left: solid; " />
                                            <td>
                                                <ul>
                                                    <li>
                                                        <p>swelling of your face, tongue, lips, or throat</p>
                                                    </li>
                                                    <li>
                                                        <p>wheezing or trouble breathing </p>
                                                    </li>
                                                    <li>
                                                        <p>skin rash, redness, or swelling </p>
                                                    </li>
                                                </ul>
                                            </td>
                                            <td style="border-right: solid; ">
                                                <ul>
                                                    <li>
                                                        <p>severe itching</p>
                                                    </li>
                                                    <li>
                                                        <p>dizziness or fainting</p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3" style="border-right: solid; border-left: solid; ">
                                                <p>The most common side effects of SOMAVERT include:</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td style="border-left: solid; " />
                                            <td>
                                                <ul>
                                                    <li>
                                                        <p>pain</p>
                                                    </li>
                                                    <li>
                                                        <p>infection</p>
                                                    </li>
                                                    <li>
                                                        <p>nausea</p>
                                                    </li>
                                                    <li>
                                                        <p>flu syndrome</p>
                                                    </li>
                                                </ul>
                                            </td>
                                            <td style="border-right: solid; ">
                                                <ul>
                                                    <li>
                                                        <p>injection site reaction</p>
                                                    </li>
                                                    <li>
                                                        <p>diarrhea</p>
                                                    </li>
                                                    <li>
                                                        <p>abnormal liver tests. If your liver test results are too
                                                            high, you may have to have more frequent liver tests</p>
                                                    </li>
                                                </ul>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p>These are not all of the possible side effects of SOMAVERT. For more
                                                    information, ask your healthcare provider or pharmacist.<br />Tell
                                                    your healthcare provider if you have any side effect that bothers
                                                    you or that does not go away.<br />Call your doctor for medical
                                                    advice about side effects. You may report side effects to FDA at
                                                    1-800-FDA-1088.</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p style="font-weight: bold; ">How should I store SOMAVERT?</p>
                                                <ul>
                                                    <li>
                                                        <p style="font-weight: bold; ">Before you mix the SOMAVERT
                                                            powder and the liquid:</p>
                                                        <ul>
                                                            <li>
                                                                <p>Store SOMAVERT in a refrigerator at 36°F to 46°F (2°C
                                                                    to 8°C). </p>
                                                            </li>
                                                            <li>
                                                                <p>The One Day Package and intermediate cartons in the
                                                                    30-Day Package containing the SOMAVERT vials, may be
                                                                    stored at room temperature up to 77°F (25°C) for a
                                                                    single period of up to 30 days.</p>
                                                                <ul>
                                                                    <li>
                                                                        <p>In the space provided on the carton, record
                                                                            the date when the carton was removed from
                                                                            the refrigerator and the discard date (30
                                                                            days after removal from the refrigerator).
                                                                        </p>
                                                                    </li>
                                                                    <li>
                                                                        <p>After the carton has been stored at room
                                                                            temperature, it should not be placed back
                                                                            into the refrigerator. If not used within 30
                                                                            days at room temperature, the vials should
                                                                            be thrown away.</p>
                                                                    </li>
                                                                </ul>
                                                            </li>
                                                        </ul>
                                                    </li>
                                                    <li>
                                                        <p>Throw away the SOMAVERT vials after the expiration date
                                                            printed on the carton or the discard date, whichever is
                                                            sooner. </p>
                                                    </li>
                                                    <li>
                                                        <p>The prefilled syringes may be stored at a temperature up to
                                                            86°F (30°C) until the expiration date printed on the carton.
                                                            After that time, they should be thrown away.</p>
                                                    </li>
                                                    <li>
                                                        <p>Do not freeze SOMAVERT.</p>
                                                    </li>
                                                    <li>
                                                        <p style="font-weight: bold; ">Read the Instructions for Use for
                                                            the right way to mix SOMAVERT.</p>
                                                    </li>
                                                    <li>
                                                        <p style="font-weight: bold; ">After you mix the SOMAVERT powder
                                                            and liquid:</p>
                                                        <ul>
                                                            <li>
                                                                <p>Keep the mixed SOMAVERT at room temperature between
                                                                    59°F to 77°F (15°C to 25°C). </p>
                                                            </li>
                                                            <li>
                                                                <p>Keep SOMAVERT inside the vial or the syringe until
                                                                    you are ready to inject it. </p>
                                                            </li>
                                                            <li>
                                                                <p><b>You must use the mixed SOMAVERT immediately after
                                                                        you mix it</b>. </p>
                                                            </li>
                                                            <li>
                                                                <p>If you have not used the mixed SOMAVERT immediately,
                                                                    throw it away. </p>
                                                            </li>
                                                        </ul>
                                                    </li>
                                                </ul>
                                                <p style="font-weight: bold; ">Keep SOMAVERT and all medicines out of
                                                    the reach of children.</p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-left: solid; border-bottom: solid; ">
                                                <p><b>General information about the safe and effective use of
                                                        SOMAVERT.</b><br />Medicines are sometimes prescribed for
                                                    purposes other than those listed in a Patient Information leaflet.
                                                    Do not use SOMAVERT for a condition for which it was not prescribed.
                                                    Do not give SOMAVERT to other people, even if they have the same
                                                    symptoms that you have. It may harm them. <br />This Patient
                                                    Information summarizes the most important information about
                                                    SOMAVERT. If you would like more information, talk with your
                                                    healthcare provider. You can ask your pharmacist or healthcare
                                                    provider for information about SOMAVERT that is written for health
                                                    professionals. </p>
                                            </td>
                                        </tr>
                                        <tr>
                                            <td colspan="3"
                                                style="border-right: solid; border-bottom: solid; border-left: solid; ">
                                                <p><b>What are the ingredients in SOMAVERT?</b><br /><b>Active
                                                        ingredient:</b> pegvisomant, including polyethylene
                                                    glycol<br /><b>Inactive ingredients:</b> glycine, mannitol, sodium
                                                    dihydrogen phosphate monohydrate, and sodium phosphate dibasic
                                                    anhydrous.</p><img src="somavert-06.jpg" alt="Logo"
                                                    id="id3501"></img>
                                                <p>U.S. License No. 1216</p>
                                                <p><br />LAB-0783-4.0<br /></p>
                                                <p>For more information, go to <a
                                                        href="https://www.somavert.com/">www.SOMAVERT.com</a> or call
                                                    1-800-645-1280.</p>
                                            </td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="b4d452ec-38aa-4eee-b29a-4dabfd704ffa">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="IFU" />
                    </extension>
                    <title value="INSTRUCTIONS FOR USE" />
                    <code><coding><system value="http://loinc.org" /><code value="59845-8" /><display value="INSTRUCTIONS FOR USE SECTION" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p style="font-weight: bold; ">SOMAVERT<sup>®</sup>
                                    (SOM-ah-vert)<br />(pegvisomant)<br />for injection, for subcutaneous use</p>
                                <p>Read these Instructions for Use before you start using SOMAVERT and each time you get
                                    a refill. There may be new information. This leaflet does not take the place of
                                    talking to your healthcare provider about your medical condition or your treatment.
                                    Your healthcare provider should show you or a caregiver how to inject SOMAVERT the
                                    right way before you inject it for the first time.</p>
                                <p>SOMAVERT is available in two types of packaging:</p>
                                <ul>
                                    <li>
                                        <p>One Day Package (containing one single-dose vial of SOMAVERT powder, a
                                            prefilled syringe, and a safety needle) </p>
                                    </li>
                                    <li>
                                        <p>30-Day Package (containing three intermediate cartons of 10 single-dose vials
                                            of SOMAVERT powder, 30 prefilled syringes, and 30 safety needles) </p>
                                    </li>
                                    <li>
                                        <p>Before you mix the SOMAVERT powder and the liquid:</p>
                                        <ul>
                                            <li>
                                                <p>Store SOMAVERT in a refrigerator at 36 ºF to 46 ºF (2 ºC to 8 ºC).
                                                </p>
                                            </li>
                                            <li>
                                                <p>The One Day Package and intermediate cartons in the 30-Day Package
                                                    containing the SOMAVERT vials, may be stored at room temperature up
                                                    to 77°F (25°C) for a single period of up to 30 days. </p>
                                                <ul>
                                                    <li>
                                                        <p>In the space provided on the carton, record the date when the
                                                            carton was removed from the refrigerator and the discard
                                                            date (30 days after removal from the refrigerator). </p>
                                                    </li>
                                                    <li>
                                                        <p>After the carton has been stored at room temperature, it
                                                            should not be placed back into the refrigerator. If not used
                                                            within 30 days at room temperature, the vials should be
                                                            thrown away.</p>
                                                    </li>
                                                </ul>
                                            </li>
                                        </ul>
                                    </li>
                                    <li>
                                        <p>Throw away the SOMAVERT vials after the expiration date printed on the carton
                                            or the discard date, whichever is sooner. </p>
                                    </li>
                                    <li>
                                        <p>The prefilled syringes may be stored at a temperature up to 86°F (30°C) until
                                            the expiration date printed on the carton. After that time, they should be
                                            thrown away.</p>
                                    </li>
                                    <li>
                                        <p>Do not freeze SOMAVERT.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Important:</p>
                                <ul>
                                    <li>
                                        <p style="font-weight: bold; ">Do not share your SOMAVERT syringes or needles
                                            with other people. You may give other people a serious infection, or get an
                                            infection from them.</p>
                                    </li>
                                    <li>
                                        <p>SOMAVERT comes in a vial as a white block of powder. You must mix SOMAVERT
                                            with a liquid (diluent) before you can use it. The liquid comes in a
                                            single-dose prefilled syringe labeled 'Sterile Water for Injection'. <b>Do
                                                not</b> use any other liquid to mix with SOMAVERT.</p>
                                    </li>
                                    <li>
                                        <p><b>You must use the mixed SOMAVERT immediately after you mix it.</b> If you
                                            have not used the mixed SOMAVERT immediately, throw it away.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 1. Things you need</p>
                                <ul>
                                    <li>
                                        <p>A vial of SOMAVERT powder.</p>
                                    </li>
                                    <li>
                                        <p>A prefilled syringe.</p>
                                    </li>
                                    <li>
                                        <p>A safety needle.</p>
                                    </li>
                                </ul>
                                <p>You will also need:</p>
                                <ul>
                                    <li>
                                        <p>A cotton ball.</p>
                                    </li>
                                    <li>
                                        <p>An alcohol swab.</p>
                                    </li>
                                    <li>
                                        <p>A sharps disposal container. <b>See "<a href="#ID_RefDispose">Dispose</a>" at
                                                the end of these instructions.</b></p>
                                    </li>
                                </ul><img src="somavert-07.jpg" alt="Image" id="id3564"></img>
                                <p style="font-weight: bold; ">Step 2. Getting ready</p>
                                <p>Before you start:</p>
                                <ul>
                                    <li>
                                        <p>Only mix SOMAVERT and the liquid when you are ready to inject your dose.</p>
                                    </li>
                                    <li>
                                        <p>SOMAVERT One Day Package: If refrigerated, remove the package and allow it to
                                            come to room temperature in a safe place for at least <b>10 minutes</b>
                                            before you need to use it.</p>
                                    </li>
                                    <li>
                                        <p>SOMAVERT 30-Day Package: If refrigerated, remove a single vial from the
                                            intermediate carton and allow it to come to room temperature in a safe place
                                            for at least <b>10 minutes</b> before you need to use it. </p>
                                    </li>
                                    <li>
                                        <p><b>Do not</b> heat the vial or syringe by using a heat source such as hot
                                            water or microwave. Let it warm up on its own.</p>
                                    </li>
                                    <li>
                                        <p>Wash your hands with soap and water, and dry completely.</p>
                                    </li>
                                    <li>
                                        <p>Peel open the packaging of the syringe and safety needle to make it easier to
                                            pick up each item as you prepare for your injection.</p>
                                    </li>
                                    <li>
                                        <p><b>Do not</b> use the syringe or vial if:</p>
                                        <ul>
                                            <li>
                                                <p>they are damaged or faulty</p>
                                            </li>
                                            <li>
                                                <p>the expiration date has passed</p>
                                            </li>
                                            <li>
                                                <p>it has been frozen, even if it has now thawed (syringe only)</p>
                                            </li>
                                        </ul>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 3. Choose injection area</p><img
                                    src="somavert-08.jpg" alt="Image" id="id3586"></img>
                                <ul>
                                    <li>
                                        <p>Choose a different location within an area for each injection.</p>
                                    </li>
                                    <li>
                                        <p>Avoid bony areas or areas that are bruised, red, sore or hard, or areas that
                                            have scars or skin conditions.</p>
                                    </li>
                                    <li>
                                        <p>Clean the injection area with the alcohol swab as instructed by your
                                            healthcare provider.</p>
                                    </li>
                                    <li>
                                        <p>Allow the injection area to dry.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 4. Remove vial cap</p><img src="somavert-09.jpg"
                                    alt="Image" id="id3594"></img>
                                <ul>
                                    <li>
                                        <p>Remove the cap from the vial.</p>
                                    </li>
                                    <li>
                                        <p>Throw the cap away. It is not needed again.<br /><b>Caution: Do not</b> let
                                            anything touch the vial stopper.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 5. Remove syringe cap </p><img src="somavert-10.jpg"
                                    alt="Image" id="id3602"></img>
                                <ul>
                                    <li>
                                        <p>Snap off the syringe cap leaving the syringe collar in place. It may take
                                            more effort to snap off than you might expect.</p>
                                    </li>
                                    <li>
                                        <p>Throw the syringe cap away. It is not needed again.</p>
                                    </li>
                                    <li>
                                        <p>Keep the syringe upright to avoid leakage.<br /><b>Caution: Do not</b> let
                                            the end of the syringe touch anything when the syringe cap is off.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 6. Attach safety needle</p><img
                                    src="somavert-11.jpg" alt="Image" id="id3611"></img>
                                <ul>
                                    <li>
                                        <p>Push down and twist the safety needle firmly onto the syringe as far as it
                                            will go.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 7. Remove needle cover</p><img src="somavert-12.jpg"
                                    alt="Image" id="id3616"></img>
                                <ul>
                                    <li>
                                        <p>Fold the needle guard out of the way of the needle cover.</p>
                                    </li>
                                    <li>
                                        <p>Carefully pull the needle cover straight off.</p>
                                    </li>
                                    <li>
                                        <p>Throw the needle cover away. It is not needed again.<br /><b>Caution:</b> Do
                                            not let the needle touch anything.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 8. Insert needle</p><img src="somavert-13.jpg"
                                    alt="Image" id="id3625"></img>
                                <ul>
                                    <li>
                                        <p>Push the needle through the center of vial stopper, as shown.</p>
                                    </li>
                                    <li>
                                        <p>Support the syringe while the needle is in the vial stopper to prevent
                                            bending the needle.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 9. Add liquid</p><img src="somavert-14.jpg"
                                    alt="Image" id="id3631"></img>
                                <ul>
                                    <li>
                                        <p>Tilt both the vial and syringe at an angle, as shown.</p>
                                    </li>
                                    <li>
                                        <p>Push the plunger rod down <b>slowly</b> until all the liquid has emptied into
                                            the vial.</p>
                                    </li>
                                    <li>
                                        <p><b>Caution: Do not</b> squirt the liquid directly onto the powder. This
                                            creates foam. Foam makes the medicine unusable.</p>
                                    </li>
                                    <li>
                                        <p style="font-weight: bold; ">Do not withdraw the needle yet.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 10. Swirl vial</p><img src="somavert-15.jpg"
                                    alt="Image" id="id3642"></img>
                                <ul>
                                    <li>
                                        <p>Support both the syringe and vial in 1 hand, as shown.</p>
                                    </li>
                                    <li>
                                        <p>Gently and <b>slowly</b> swirl the liquid, sliding the vial in a circular
                                            motion on a flat surface.</p>
                                    </li>
                                    <li>
                                        <p>Continue swirling the liquid until all the powder has fully
                                            dissolved.<br /><b>Note:</b> This may take up to 5 minutes.<br /><b>Do not
                                                shake.</b></p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 11. Check medicine</p><img src="somavert-16.jpg"
                                    alt="Image" id="id3654"></img>
                                <ul>
                                    <li>
                                        <p>Keeping the needle in the vial, look carefully at the medicine. It must be
                                            clear and free of particles.</p>
                                    </li>
                                    <li>
                                        <p><b>Do not</b> use if:</p>
                                        <ul>
                                            <li>
                                                <p>the medicine is cloudy or hazy</p>
                                            </li>
                                            <li>
                                                <p>the medicine has any color at all</p>
                                            </li>
                                            <li>
                                                <p>there are any particles or foam in the vial</p>
                                            </li>
                                        </ul>
                                    </li>
                                    <li>
                                        <p>If you have any doubts about your medication go to <a
                                                href="https://www.somavert.com/">www.SOMAVERT.com</a> or call
                                            1-800-645-1280.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 12. Reposition needle</p><img src="somavert-17.jpg"
                                    alt="Image" id="id3666"></img>
                                <ul>
                                    <li>
                                        <p>Turn the vial so that you can see the stopper gap, as shown.</p>
                                    </li>
                                    <li>
                                        <p>Pull the needle down so that the needle tip is at the lowest point in the
                                            liquid. This will help you to draw off as much liquid as possible.</p>
                                    </li>
                                    <li>
                                        <p>Check that the plunger rod has not moved. If the plunger rod has moved, then
                                            push it back all the way into the syringe. This ensures that all air is
                                            removed from the syringe before you draw off the dose.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 13. Draw off dose</p><img src="somavert-18.jpg"
                                    alt="Image" id="id3673"></img>
                                <ul>
                                    <li>
                                        <p>Slowly pull back the plunger rod to withdraw as much medicine as possible
                                            from the vial.<br /><b>Note:</b> If you see air in the syringe, tap the
                                            barrel to float the bubbles to the top, and then gently push the bubbles out
                                            <b>into the vial</b>.</p>
                                    </li>
                                    <li>
                                        <p>Pull the needle out of the vial.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 14. Insert needle</p><img src="somavert-19.jpg"
                                    alt="Image" id="id3682"></img>
                                <ul>
                                    <li>
                                        <p>Gently pinch the skin at the site of injection.</p>
                                    </li>
                                    <li>
                                        <p>Insert the needle to its full depth into the pinched skin.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 15. Inject medicine</p><img src="somavert-20.jpg"
                                    alt="Image" id="id3688"></img>
                                <ul>
                                    <li>
                                        <p>Push the plunger rod down slowly until the barrel is empty.<br /><b>Note:</b>
                                            Make sure you keep the needle in at full depth. </p>
                                    </li>
                                    <li>
                                        <p>Release the pinched skin and pull the needle straight out.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 16. Make needle safe</p><img src="somavert-21.jpg"
                                    alt="Image" id="id3696"></img>
                                <ul>
                                    <li>
                                        <p>Fold the needle guard over the needle.<br /><b>Gently</b> apply pressure
                                            using a hard surface to lock the needle guard in place.</p>
                                    </li>
                                    <li>
                                        <p>Note: You will hear a click when the needle guard has been locked.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 17. Dispose</p><img src="somavert-22.jpg"
                                    alt="Image" id="id3704"></img>
                                <ul>
                                    <li>
                                        <p>Put your used syringes in a FDA cleared sharps disposal container right away
                                            after use. </p>
                                    </li>
                                    <li>
                                        <p>Do not throw away (dispose of) syringes in your household trash.<br />Note:
                                            If you do not have a FDA cleared sharps disposal container, please refer to
                                            the safe syringe disposal information on the right hand side of this
                                            leaflet.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Step 18. After injection</p><img src="somavert-23.jpg"
                                    alt="Image" id="id3711"></img>
                                <ul>
                                    <li>
                                        <p>If necessary, use a clean cotton ball and press lightly on the injection
                                            area.</p>
                                    </li>
                                    <li>
                                        <p style="font-weight: bold; ">Do not rub the area.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">QUESTIONS AND ANSWERS</p>
                                <p style="font-weight: bold; ">What should I do if anything has accidentally touched the
                                    vial stopper?</p>
                                <ul>
                                    <li>
                                        <p>Clean the vial stopper with a fresh alcohol wipe, and leave it to dry
                                            completely. If you are unable to clean the stopper, do not use the vial.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">What should I do with the syringe if it has been dropped?
                                </p>
                                <ul>
                                    <li>
                                        <p>Do not use it even if it looks undamaged. Dispose of the syringe in the same
                                            way as a used syringe. You will need a replacement syringe.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">How many times can I safely insert the needle into the
                                    vial stopper?</p>
                                <ul>
                                    <li>
                                        <p>Only 1 time. Withdrawing and reinserting greatly increases the risk of needle
                                            damage, and will blunt the needle. This can cause discomfort and increases
                                            risk of skin damage and infection. There is also a risk you may lose some of
                                            the medicine.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Is it okay to shake the vial if the powder is not
                                    dissolving?</p>
                                <ul>
                                    <li>
                                        <p>No. Never shake the vial. Shaking can destroy the medicine and create foam.
                                            The powder may take a few minutes to dissolve fully, so continue swirling
                                            the vial gently until the liquid is completely clear.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">How can I tell if there is any foam in the vial?</p>
                                <ul>
                                    <li>
                                        <p>Foam looks like a mass of small bubbles that float as a layer to the top of
                                            the liquid. Do not inject SOMAVERT if it has foamed.</p>
                                    </li>
                                </ul><img src="somavert-24.jpg" alt="Image" id="id3738"></img>
                                <p style="font-weight: bold; ">How can I prevent the medicine from foaming?</p>
                                <ul>
                                    <li>
                                        <p>Press the plunger very slowly so that the liquid gently runs down the inside
                                            of the vial. Do not spray the liquid directly onto the powder, because this
                                            creates foam. This will also reduce the swirling time and allow more of the
                                            medicine to be drawn off.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">I can see some air in the syringe. Is this okay?</p>
                                <ul>
                                    <li>
                                        <p>Tiny air bubbles in the liquid are normal and are safe to inject. However, it
                                            is possible to accidently draw air into the syringe, which should be removed
                                            before injecting. Bubbles or air gaps that float to the top of the liquid
                                            should be pushed back out into the vial.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Why can I not get all of the medicine out of the vial?
                                </p>
                                <ul>
                                    <li>
                                        <p>The shape of the vial means that a very small amount of the medicine will be
                                            left behind in the vial. This is normal. To ensure that only a trace of
                                            medicine remains, make sure the needle tip is as low as it can be in the
                                            vial when drawing off your dose.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">What should I do if I have any doubts about my medicine?
                                </p>
                                <ul>
                                    <li>
                                        <p>For more information, go to <a
                                                href="https://www.somavert.com/">www.SOMAVERT.com</a> or call
                                            1-800-645-1280.</p>
                                    </li>
                                </ul>
                                <p style="font-weight: bold; ">Safe syringe disposal information</p>
                                <p>If you do not have a FDA-cleared sharps disposal container, you may use a household
                                    container that is:</p>
                                <ul>
                                    <li>
                                        <p id="_RefIFU">made of heavy-duty plastic, </p>
                                    </li>
                                    <li>
                                        <p>can be closed with a tight-fitting, puncture-resistant lid, without sharps
                                            being able to come out,</p>
                                    </li>
                                    <li>
                                        <p>upright and stable during use, leak-resistant, and</p>
                                    </li>
                                    <li>
                                        <p>properly labeled to warn of hazardous waste inside the container.</p>
                                    </li>
                                </ul>
                                <p>When your sharps disposal container is almost full, you will need to follow your
                                    community guidelines for the right way to dispose of your sharps disposal container.
                                    There may be state or local laws about how you should throw away used needles and
                                    syringes.</p>
                                <p>For more information about safe sharps disposal, and for specific information about
                                    sharps disposal in the state that you live in, go to the FDA's website at: <a
                                        href="http://www.fda.gov/safesharpdisposal">http://www.fda.gov/safesharpdisposal</a>
                                </p>
                                <p>This Instructions for Use has been approved by the U.S. Food and Drug Administration.
                                </p><img src="somavert-25.jpg" alt="Logo" id="id3766"></img>
                                <p>U.S. License No. 1216<br />LAB-0784-3.0<br />Revised: July 2023</p>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="24c3a649-0ecc-47c7-bc81-d72746a23391">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_9d932e27-4f67-4211-b1c7-9e63c5dccaba" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>1 mL SINGLE-DOSE<br />NDC 0009-5936-01</p>
                                <p>Sterile Water for Injection, USP</p>
                                <p>For reconstitution of SOMAVERT<sup>®</sup><br />Contains no antimicrobial or
                                    other<br />added substance. Sterile, nonpyrogenic.</p>
                                <p>Manufactured by<br />Pharmacia &amp; Upjohn Company LLC<br />A subsidiary of Pfizer
                                    Inc.<br />New York, NY 10001<br />U.S. License No. 1216</p>
                                <p>LOT/EXP<br />Rx only</p>
                                <p>PAA213086</p><img src="image-01.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label" id="id3889"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="6ec3c33e-c188-4f08-8482-3aa8cd5c92f5">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_497fe17e-82ef-4781-8b07-9aa878289ca1" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 10 mg Vial Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5175-02</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>10 mg/vial</p>
                                <p>For Subcutaneous Use Only</p>
                                <p>One Single-Dose Vial <br />Discard unused portion.</p>
                                <p>Rx only</p>
                                <p>PAA213088</p><img src="somavert-27.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 10 mg Vial Label" id="id3914"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="60a7aa05-e1a0-452e-97b0-1623569b742c">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_d461285a-2acf-43fb-b34d-91720b2f229d" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7166-01" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7166-01</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>10 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>One Single-Dose Vial <br />Discard unused portion. <br />Contents: One Somavert
                                    single-dose vial, one diluent prefilled <br />syringe containing 1 mL Sterile Water
                                    for Injection, USP and <br />one 27 gauge ½ inch safety needle.</p>
                                <p>Rx only</p><img src="somavert-28.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7166-01" id="id3941"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="7757d0c8-06df-42f6-aaf9-3b0b104cddb1">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_1b14a58d-e3df-4c45-bee8-7e115f8a927c" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 10 mg Vial Carton" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5175-10</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>10 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials <br />Discard unused portion.</p>
                                <p>Contents of intermediate carton: <br />Ten single-dose vials of Somavert</p>
                                <p>Rx only</p><img src="somavert-29.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 10 mg Vial Carton" id="id3967"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="4a7ac342-84b6-49e7-b50d-5fb2949f2431">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_383d65ec-686c-435a-9ce6-5c490a53ef4d" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7166-30" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7166-30</p>
                                <p>Pfizer <br />Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>10 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials <br />Discard unused portion. <br />Contents of outer carton:
                                    <br />Three intermediate cartons (each containing ten single-dose vials of
                                    <br />Somavert), thirty diluent prefilled syringes containing 1 mL Sterile
                                    <br />Water for Injection, USP and thirty 27 gauge ½ inch safety needles.</p>
                                <p>Rx only</p><img src="somavert-30.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7166-30" id="id3995"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="15bf66cc-6e5a-4db1-a2e7-7bc4106f82a5">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_79442010-172c-4c7e-bf55-9851af0aadb8" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 15 mg Vial Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5177-02</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>15 mg/vial</p>
                                <p>For Subcutaneous Use Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.</p>
                                <p>Rx only</p>
                                <p>PAA213202</p><img src="somavert-31.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 15 mg Vial Label" id="id4020"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="666cc573-355a-42e2-8fad-bfc81556eb15">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_2f403914-d5d5-4ad7-93c2-357ae0f0530f" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7168-01" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7168-01</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>15 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>One Single-Dose Vial <br />Discard unused portion. <br />Contents: One Somavert
                                    single-dose vial, one diluent prefilled <br />syringe containing 1 mL Sterile Water
                                    for Injection, USP and <br />one 27 gauge ½ inch safety needle.</p>
                                <p>Rx only</p><img src="somavert-32.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7168-01" id="id4047"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="aa7099f9-dd58-405d-a3f0-5b96a59ee75c">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_0116cce1-a5b6-497c-80bc-01272bf5d4c9" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 15 mg Vial Carton" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5177-10</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>15 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of intermediate carton:<br />Ten single-dose vials of Somavert</p>
                                <p>Rx only</p><img src="somavert-33.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 15 mg Vial Carton" id="id4073"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="b335a2f8-5160-4985-abdc-ffa046f74eea">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_79ee47e3-8b09-4532-8009-8cd2607ae0e3" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7168-30" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7168-30</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>15 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.<br />Contents of outer
                                    carton:<br />Three intermediate cartons (each containing ten single-dose<br />vials
                                    of Somavert), thirty diluent prefilled syringes containing<br />1 mL Sterile Water
                                    for Injection, USP and thirty 27 gauge ½<br />inch safety needles.</p>
                                <p>Rx only</p><img src="somavert-34.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7168-30" id="id4102"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="aa01f4d9-7540-43b9-89d4-1767953f19b0">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_9d21793f-bf27-425c-8ae2-2525d90db10d" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 20 mg Vial Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5179-02</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>20 mg/vial</p>
                                <p>For Subcutaneous Use Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.</p>
                                <p>Rx only</p>
                                <p>PAA213206</p><img src="somavert-35.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 20 mg Vial Label" id="id4127"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="415237e1-03c8-4ad2-87a5-d2d4af64022c">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_129474e2-169a-4345-8edd-aab72ef3a793" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7188-01" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7188-01</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>20 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.</p>
                                <p>Contents: One Somavert single-dose vial, one diluent prefilled<br />syringe
                                    containing 1 mL Sterile Water for Injection, USP and<br />one 27 gauge ½ inch safety
                                    needle.</p>
                                <p>Rx only</p><img src="somavert-36.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7188-01" id="id4154"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="87d30680-a318-4ee7-a723-205ef7ef1a31">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_b98c5104-4955-4323-ae48-dc09c2070765" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 20 mg Vial Carton" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5179-10</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>20 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of intermediate carton:<br />Ten single-dose vials of Somavert</p>
                                <p>Rx only</p><img src="somavert-37.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 20 mg Vial Carton" id="id4180"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="c1c76f78-7865-453b-9013-44076fb64364">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_198e7b53-4724-4cd7-ac75-6d92a0553130" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7188-30" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7188-30</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>20 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of outer carton:<br />Three intermediate cartons (each containing ten
                                    single-dose<br />vials of Somavert), thirty diluent prefilled syringes containing 1
                                    mL<br />Sterile Water for Injection, USP and thirty 27 gauge ½ inch<br />safety
                                    needles.</p>
                                <p>Rx only</p><img src="somavert-38.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7188-30" id="id4209"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="4bb5c27a-15c6-47a9-ae02-96f816eac50a">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_572c4649-96dc-4c86-8ab0-076831c96dd3" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 25 mg Vial Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5201-04</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>25 mg/vial</p>
                                <p>For Subcutaneous Use Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.</p>
                                <p>Rx only</p>
                                <p>PAA213210</p><img src="somavert-39.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 25 mg Vial Label" id="id4234"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="717145eb-6141-40ed-be9f-99b17fc3daae">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_f8508243-ec89-4e9a-b303-8203ba83a6e0" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7199-01" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7199-01</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>25 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.<br />Contents: One Somavert
                                    single-dose vial, one diluent prefilled<br />syringe containing 1 mL Sterile Water
                                    for Injection, USP and<br />one 27 gauge ½ inch safety needle.</p>
                                <p>Rx only</p><img src="somavert-40.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7199-01" id="id4261"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="c64cb32c-8a6a-48fb-8b3d-ab9e7dfa2657">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_7bb6300e-fbe7-4561-a377-36f3760b212b" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 25 mg Vial Carton" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5201-10</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>25 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of intermediate carton:<br />Ten single-dose vials of Somavert</p>
                                <p>Rx only</p><img src="somavert-41.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 25 mg Vial Carton" id="id4287"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="d40c5328-0416-48ea-a5f8-9dd3299b5f9b">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_dbb6f37b-d2d3-4fab-a48b-004938720c6e" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7199-30" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7199-30</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>25 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of outer carton:<br />Three intermediate cartons (each containing ten
                                    single-dose<br />vials of Somavert), thirty diluent prefilled syringes
                                    containing<br />1 mL Sterile Water for Injection, USP and thirty 27 gauge ½
                                    inch<br />safety needles.</p>
                                <p>Rx only</p><img src="somavert-42.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7199-30" id="id4316"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="09832158-e948-4d76-bfb9-660c3ab37e2d">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_42a9e5fa-9f8e-409b-98b2-3dd8c871a5ef" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 30 mg Vial Label" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5376-04</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>30 mg/vial</p>
                                <p>For Subcutaneous Use Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion.</p>
                                <p>Rx only</p>
                                <p>PAA213244</p><img src="somavert-43.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 30 mg Vial Label" id="id4341"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="adac371f-1feb-4774-91d0-50d5d92d4557">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_698d708c-6c53-47b3-a627-ca9702bfc80d" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7200-01" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7200-01</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>30 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>One Single-Dose Vial<br />Discard unused portion. <br />Contents: One Somavert
                                    single-dose vial, one diluent prefilled<br />syringe containing 1 mL Sterile Water
                                    for Injection, USP and<br />one 27 gauge ½ inch safety needle.</p>
                                <p>Rx only</p><img src="somavert-44.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7200-01" id="id4368"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="5eeb8a22-d085-44fa-bf76-5b1c08665b99">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_838738ee-e3dc-4341-adf5-5821ad039b7f" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - 30 mg Vial Carton" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-5376-10</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>30 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.</p>
                                <p>Contents of intermediate carton:<br />Ten single-dose vials of Somavert</p>
                                <p>Rx only</p><img src="somavert-45.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - 30 mg Vial Carton" id="id4394"></img>
                            </div>
                        </div>
                    </text>
                </section>
                <section id="cb57b9eb-86be-45bb-bc61-d7c6fb3bcd2b">
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionEffectiveTime">
                        <valueDateTime value="2023-07-27" />
                    </extension>
                    <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/sectionLinkId">
                        <valueString value="ID_018ff1d1-ab5a-4f86-b5ba-1c97f1b1b33a" />
                    </extension>
                    <title value="PRINCIPAL DISPLAY PANEL - Kit Carton - 7200-30" />
                    <code><coding><system value="http://loinc.org" /><code value="51945-4" /><display value="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL" /></coding></code><text>
                        <status value="additional" />
                        <div xmlns="http://www.w3.org/1999/xhtml">
                            <div style="narrative">
                                <p>NDC 0009-7200-30</p>
                                <p>Pfizer</p>
                                <p>Somavert<sup>®</sup><br />(pegvisomant) for injection</p>
                                <p>30 mg/vial</p>
                                <p>For Subcutaneous Injection Only</p>
                                <p>Single-Dose Vials<br />Discard unused portion.<br />Contents of outer
                                    carton:<br />Three intermediate cartons (each containing ten single-dose<br />vials
                                    of Somavert), thirty diluent prefilled syringes containing 1 mL<br />Sterile Water
                                    for Injection, USP and thirty 27 gauge ½ inch safety<br />needles.</p>
                                <p>Rx only</p><img src="somavert-46.jpg"
                                    alt="PRINCIPAL DISPLAY PANEL - Kit Carton - 7200-30" id="id4423"></img>
                            </div>
                        </div>
                    </text>
                </section>
            </Composition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Organization/Labeler-618054084" />
        <resource>
            <Organization>
                <id value="Labeler-618054084" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedLabeler" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">Pharmacia &amp; Upjohn Company LLC (DUNS: 618054084)
                        Organization</div>
                </text>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="618054084" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                            value="Labeler" />
                    </coding>
                </type>
                <name value="Pharmacia &amp; Upjohn Company LLC" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Organization/Establishment-370156507" />
        <resource>
            <Organization>
                <id value="Establishment-370156507" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">Pfizer Manufacturing Belgium NV (DUNS: 370156507)
                        Organization</div>
                </text>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="370156507" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                            value="Establishment" />
                    </coding>
                </type>
                <name value="Pfizer Manufacturing Belgium NV" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Organization/Establishment-985586408" />
        <resource>
            <Organization>
                <id value="Establishment-985586408" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">Pfizer Ireland Pharmaceuticals (DUNS: 985586408)
                        Organization</div>
                </text>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="985586408" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                            value="Establishment" />
                    </coding>
                </type>
                <name value="Pfizer Ireland Pharmaceuticals" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Organization/Establishment-618054084" />
        <resource>
            <Organization>
                <id value="Establishment-618054084" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/IdentifiedEstablishment" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">Pharmacia &amp; Upjohn Company LLC (DUNS: 618054084)
                        Organization</div>
                </text>
                <identifier>
                    <system value="urn:oid:1.3.6.1.4.1.519.1" />
                    <value value="618054084" />
                </identifier>
                <type>
                    <coding>
                        <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                            value="Establishment" />
                    </coding>
                </type>
                <name value="Pharmacia &amp; Upjohn Company LLC" />
            </Organization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-7166" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-7166" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-7166]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-7166" />
                </identifier>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C82401" />
                                <display value="API MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5175" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-5175]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5175" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5936" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5936" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">STERILE WATER (Water) [0009-5936]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5936" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="STERILE WATER" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="Water" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0E53LO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0E53LO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) KIT []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C47916" />
                        <display value="KIT" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EGAMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EGAMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) INJECTION, POWDER, LYOPHILIZED, FOR
                        SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42957" />
                        <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0E5EMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0E5EMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">STERILE WATER (Water) INJECTION, SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42945" />
                        <display value="INJECTION, SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/N824AOU5XV-10mg-0009-5175" />
        <resource>
            <Ingredient>
                <id value="N824AOU5XV-10mg-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="ACTIB" />
                    </coding>
                </role>
                <substance><code><reference><reference value="SubstanceDefinition/N824AOU5XV" /></reference></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="10" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/TE7660XO1C-1.36mg-0009-5175" />
        <resource>
            <Ingredient>
                <id value="TE7660XO1C-1.36mg-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">GLYCINE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="TE7660XO1C" /><display value="GLYCINE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/3OWL53L36A-36mg-0009-5175" />
        <resource>
            <Ingredient>
                <id value="3OWL53L36A-36mg-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">MANNITOL Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="3OWL53L36A" /><display value="MANNITOL" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/22ADO53M6F-1.04mg-0009-5175" />
        <resource>
            <Ingredient>
                <id value="22ADO53M6F-1.04mg-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="22ADO53M6F" /><display value="SODIUM PHOSPHATE, DIBASIC, ANHYDROUS" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.04" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/593YOG76RN-0.36mg-0009-5175" />
        <resource>
            <Ingredient>
                <id value="593YOG76RN-0.36mg-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="593YOG76RN" /><display value="SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="0.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/059QF0KO0R-1mL-0009-5936" />
        <resource>
            <Ingredient>
                <id value="059QF0KO0R-1mL-0009-5936" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">WATER Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E5EMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="059QF0KO0R" /><display value="WATER" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7166-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7166-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">CARTON (0009-7166-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7166" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7166-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0E53LO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <system value="http://unitsofmeasure.org" /><code value="1" />
                        </amount>
                    </containedItem>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5175-02" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5175" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42957" />
                                <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5936-01" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5936" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42945" />
                                <display value="INJECTION, SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0E5EMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7166-30" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7166-30" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">KIT (0009-7166-30</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7166" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2022-01-17" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7166-30" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <package>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43197" />
                                <display value="KIT" />
                            </coding>
                        </type>
                        <quantity value="30" />
                        <property>
                            <type>
                                <coding>
                                    <system
                                        value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                    <code value="SPLCMBPRDTP" />
                                </coding>
                            </type>
                            <valueCodeableConcept>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C112160" />
                                    <display value="Type 0: Not a Combination Product" />
                                </coding>
                            </valueCodeableConcept>
                        </property>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0E53LO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <system value="http://unitsofmeasure.org" /><code value="1" />
                            </amount>
                        </containedItem>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5175-02" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5175" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42957" />
                                    <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5936-01" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5936" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42945" />
                                    <display value="INJECTION, SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0E5EMO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5175-02" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5175-02" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">VIAL, SINGLE-DOSE (0009-5175-02</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5175" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5175-02" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43215" />
                            <display value="VIAL, SINGLE-DOSE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EGAMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5936-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5936-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SYRINGE (0009-5936-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5936" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5936-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43202" />
                            <display value="SYRINGE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C102835" />
                                <display value="Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0E5EMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-7166" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-7166" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-7166" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5175" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5175" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5175" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5936" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5936" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5936" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-7168" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-7168" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-7168]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-7168" />
                </identifier>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C82401" />
                                <display value="API MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5177" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-5177]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5177" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EQIMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EQIMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) KIT []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C47916" />
                        <display value="KIT" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EYLMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EYLMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) INJECTION, POWDER, LYOPHILIZED, FOR
                        SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42957" />
                        <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/N824AOU5XV-15mg-0009-5177" />
        <resource>
            <Ingredient>
                <id value="N824AOU5XV-15mg-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="ACTIB" />
                    </coding>
                </role>
                <substance><code><reference><reference value="SubstanceDefinition/N824AOU5XV" /></reference></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="15" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/TE7660XO1C-1.36mg-0009-5177" />
        <resource>
            <Ingredient>
                <id value="TE7660XO1C-1.36mg-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">GLYCINE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="TE7660XO1C" /><display value="GLYCINE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/3OWL53L36A-36mg-0009-5177" />
        <resource>
            <Ingredient>
                <id value="3OWL53L36A-36mg-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">MANNITOL Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="3OWL53L36A" /><display value="MANNITOL" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/22ADO53M6F-1.04mg-0009-5177" />
        <resource>
            <Ingredient>
                <id value="22ADO53M6F-1.04mg-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="22ADO53M6F" /><display value="SODIUM PHOSPHATE, DIBASIC, ANHYDROUS" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.04" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/593YOG76RN-0.36mg-0009-5177" />
        <resource>
            <Ingredient>
                <id value="593YOG76RN-0.36mg-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="593YOG76RN" /><display value="SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="0.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7168-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7168-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">CARTON (0009-7168-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7168" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7168-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EQIMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <system value="http://unitsofmeasure.org" /><code value="1" />
                        </amount>
                    </containedItem>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5177-02" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5177" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42957" />
                                <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5936-01" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5936" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42945" />
                                <display value="INJECTION, SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EQQMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7168-30" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7168-30" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">KIT (0009-7168-30</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7168" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2022-01-17" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7168-30" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <package>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43197" />
                                <display value="KIT" />
                            </coding>
                        </type>
                        <quantity value="30" />
                        <property>
                            <type>
                                <coding>
                                    <system
                                        value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                    <code value="SPLCMBPRDTP" />
                                </coding>
                            </type>
                            <valueCodeableConcept>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C112160" />
                                    <display value="Type 0: Not a Combination Product" />
                                </coding>
                            </valueCodeableConcept>
                        </property>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EQIMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <system value="http://unitsofmeasure.org" /><code value="1" />
                            </amount>
                        </containedItem>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5177-02" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5177" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42957" />
                                    <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5936-01" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5936" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42945" />
                                    <display value="INJECTION, SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EQQMO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5177-02" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5177-02" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">VIAL, SINGLE-DOSE (0009-5177-02</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5177" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5177-02" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43215" />
                            <display value="VIAL, SINGLE-DOSE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EYLMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-7168" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-7168" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-7168" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5177" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5177" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5177" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-7188" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-7188" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-7188]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-7188" />
                </identifier>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C82401" />
                                <display value="API MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5179" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-5179]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5179" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0ECUMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0ECUMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) KIT []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C47916" />
                        <display value="KIT" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EKXMO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EKXMO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) INJECTION, POWDER, LYOPHILIZED, FOR
                        SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42957" />
                        <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/N824AOU5XV-20mg-0009-5179" />
        <resource>
            <Ingredient>
                <id value="N824AOU5XV-20mg-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="ACTIB" />
                    </coding>
                </role>
                <substance><code><reference><reference value="SubstanceDefinition/N824AOU5XV" /></reference></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="20" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/TE7660XO1C-1.36mg-0009-5179" />
        <resource>
            <Ingredient>
                <id value="TE7660XO1C-1.36mg-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">GLYCINE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="TE7660XO1C" /><display value="GLYCINE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/3OWL53L36A-36mg-0009-5179" />
        <resource>
            <Ingredient>
                <id value="3OWL53L36A-36mg-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">MANNITOL Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="3OWL53L36A" /><display value="MANNITOL" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/22ADO53M6F-1.04mg-0009-5179" />
        <resource>
            <Ingredient>
                <id value="22ADO53M6F-1.04mg-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="22ADO53M6F" /><display value="SODIUM PHOSPHATE, DIBASIC, ANHYDROUS" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.04" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/593YOG76RN-0.36mg-0009-5179" />
        <resource>
            <Ingredient>
                <id value="593YOG76RN-0.36mg-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="593YOG76RN" /><display value="SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="0.36" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7188-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7188-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">CARTON (0009-7188-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7188" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7188-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0ECUMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <system value="http://unitsofmeasure.org" /><code value="1" />
                        </amount>
                    </containedItem>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5179-02" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5179" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42957" />
                                <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5936-01" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5936" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42945" />
                                <display value="INJECTION, SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EC3MO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7188-30" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7188-30" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">KIT (0009-7188-30</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7188" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2022-01-17" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7188-30" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <package>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43197" />
                                <display value="KIT" />
                            </coding>
                        </type>
                        <quantity value="30" />
                        <property>
                            <type>
                                <coding>
                                    <system
                                        value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                    <code value="SPLCMBPRDTP" />
                                </coding>
                            </type>
                            <valueCodeableConcept>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C112160" />
                                    <display value="Type 0: Not a Combination Product" />
                                </coding>
                            </valueCodeableConcept>
                        </property>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0ECUMO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <system value="http://unitsofmeasure.org" /><code value="1" />
                            </amount>
                        </containedItem>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5179-02" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5179" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42957" />
                                    <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5936-01" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5936" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42945" />
                                    <display value="INJECTION, SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EC3MO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5179-02" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5179-02" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">VIAL, SINGLE-DOSE (0009-5179-02</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5179" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5179-02" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43215" />
                            <display value="VIAL, SINGLE-DOSE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EKXMO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-7188" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-7188" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-7188" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5179" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5179" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5179" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-7199" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-7199" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-7199]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-7199" />
                </identifier>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C82401" />
                                <display value="API MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5201" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-5201]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5201" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EU6MO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EU6MO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) KIT []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C47916" />
                        <display value="KIT" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0E3CNO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0E3CNO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) INJECTION, POWDER, LYOPHILIZED, FOR
                        SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42957" />
                        <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/N824AOU5XV-25mg-0009-5201" />
        <resource>
            <Ingredient>
                <id value="N824AOU5XV-25mg-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="ACTIB" />
                    </coding>
                </role>
                <substance><code><reference><reference value="SubstanceDefinition/N824AOU5XV" /></reference></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="25" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/TE7660XO1C-1.7mg-0009-5201" />
        <resource>
            <Ingredient>
                <id value="TE7660XO1C-1.7mg-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">GLYCINE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="TE7660XO1C" /><display value="GLYCINE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.7" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/3OWL53L36A-45mg-0009-5201" />
        <resource>
            <Ingredient>
                <id value="3OWL53L36A-45mg-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">MANNITOL Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="3OWL53L36A" /><display value="MANNITOL" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="45" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/22ADO53M6F-1.3mg-0009-5201" />
        <resource>
            <Ingredient>
                <id value="22ADO53M6F-1.3mg-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="22ADO53M6F" /><display value="SODIUM PHOSPHATE, DIBASIC, ANHYDROUS" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.3" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/593YOG76RN-0.45mg-0009-5201" />
        <resource>
            <Ingredient>
                <id value="593YOG76RN-0.45mg-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="593YOG76RN" /><display value="SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="0.45" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7199-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7199-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">CARTON (0009-7199-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7199" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7199-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EU6MO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <system value="http://unitsofmeasure.org" /><code value="1" />
                        </amount>
                    </containedItem>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5201-04" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5201" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42957" />
                                <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5936-01" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5936" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42945" />
                                <display value="INJECTION, SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EUHNO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7199-30" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7199-30" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">KIT (0009-7199-30</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7199" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2022-01-17" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7199-30" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <package>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43197" />
                                <display value="KIT" />
                            </coding>
                        </type>
                        <quantity value="30" />
                        <property>
                            <type>
                                <coding>
                                    <system
                                        value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                    <code value="SPLCMBPRDTP" />
                                </coding>
                            </type>
                            <valueCodeableConcept>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C112160" />
                                    <display value="Type 0: Not a Combination Product" />
                                </coding>
                            </valueCodeableConcept>
                        </property>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EU6MO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <system value="http://unitsofmeasure.org" /><code value="1" />
                            </amount>
                        </containedItem>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5201-04" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5201" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42957" />
                                    <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5936-01" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5936" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42945" />
                                    <display value="INJECTION, SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EUHNO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5201-04" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5201-04" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">VIAL, SINGLE-DOSE (0009-5201-04</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5201" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5201-04" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43215" />
                            <display value="VIAL, SINGLE-DOSE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0E3CNO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-7199" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-7199" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-7199" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5201" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5201" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5201" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-7200" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-7200" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-7200]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-7200" />
                </identifier>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43360" />
                                <display value="MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-370156507" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C25391" />
                                <display value="ANALYSIS" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C82401" />
                                <display value="API MANUFACTURE" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-985586408" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84731" />
                                <display value="PACK" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
                <operation>
                    <type>
                        <concept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C84732" />
                                <display value="LABEL" />
                            </coding>
                        </concept>
                    </type>
                    <organization>
                        <reference value="Organization/Establishment-618054084" />
                    </organization>
                </operation>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/MedicinalProductDefinition/0009-5376" />
        <resource>
            <MedicinalProductDefinition>
                <id value="0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProduct" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) [0009-5376]</div>
                </text>
                <identifier>
                    <system value="http://hl7.org/fhir/sid/ndc" />
                    <value value="0009-5376" />
                </identifier>
                <route>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C38299" />
                        <display value="SUBCUTANEOUS" />
                    </coding>
                </route>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-11-01" />
                    </dateRange>
                </marketingStatus>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-370156507" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-985586408" />
                    </contact>
                </contact>
                <contact>
                    <type>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-organizationTypes" /><code
                                value="Establishment" />
                        </coding>
                    </type>
                    <contact>
                        <reference value="Organization/Establishment-618054084" />
                    </contact>
                </contact>
                <name>
                    <productName value="SOMAVERT" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="PROPRIETARY" />
                        </coding>
                    </type>
                </name>
                <name>
                    <productName value="pegvisomant" />
                    <type>
                        <coding>
                            <system
                                value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-submittedMedicinalProductNameTypes" />
                            <code value="NONPROPRIETARY" />
                        </coding>
                    </type>
                </name>
            </MedicinalProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EGLNO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EGLNO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) KIT []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C47916" />
                        <display value="KIT" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/ManufacturedItemDefinition/ID0EOONO" />
        <resource>
            <ManufacturedItemDefinition>
                <id value="ID0EOONO" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedManufacturedItem" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SOMAVERT (pegvisomant) INJECTION, POWDER, LYOPHILIZED, FOR
                        SOLUTION []</div>
                </text>
                <status value="active" />
                <manufacturedDoseForm>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C42957" />
                        <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                    </coding>
                </manufacturedDoseForm>
            </ManufacturedItemDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/N824AOU5XV-30mg-0009-5376" />
        <resource>
            <Ingredient>
                <id value="N824AOU5XV-30mg-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="ACTIB" />
                    </coding>
                </role>
                <substance><code><reference><reference value="SubstanceDefinition/N824AOU5XV" /></reference></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="30" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/TE7660XO1C-2.04mg-0009-5376" />
        <resource>
            <Ingredient>
                <id value="TE7660XO1C-2.04mg-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">GLYCINE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="TE7660XO1C" /><display value="GLYCINE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="2.04" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/3OWL53L36A-54mg-0009-5376" />
        <resource>
            <Ingredient>
                <id value="3OWL53L36A-54mg-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">MANNITOL Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="3OWL53L36A" /><display value="MANNITOL" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="54" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/22ADO53M6F-1.56mg-0009-5376" />
        <resource>
            <Ingredient>
                <id value="22ADO53M6F-1.56mg-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, DIBASIC, ANHYDROUS Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="22ADO53M6F" /><display value="SODIUM PHOSPHATE, DIBASIC, ANHYDROUS" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="1.56" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/Ingredient/593YOG76RN-0.54mg-0009-5376" />
        <resource>
            <Ingredient>
                <id value="593YOG76RN-0.54mg-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductIngredient" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Ingredient</div>
                </text>
                <status value="active" />
                <for>
                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                </for>
                <role>
                    <coding>
                        <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass" /><code value="IACT" />
                    </coding>
                </role>
                <substance>
                    <code><concept><coding><system value="http://fdasis.nlm.nih.gov" /><code value="593YOG76RN" /><display value="SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE" /></coding></concept></code>
                    <strength>
                        <presentationRatio>
                            <numerator>
                                <value value="0.54" />
                                <unit value="mg" />
                                <system value="http://unitsofmeasure.org" /><code value="mg" />
                            </numerator>
                            <denominator>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </denominator>
                        </presentationRatio>
                    </strength>
                </substance>
            </Ingredient>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7200-01" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7200-01" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">CARTON (0009-7200-01</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7200" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2016-10-01" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7200-01" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EGLNO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <system value="http://unitsofmeasure.org" /><code value="1" />
                        </amount>
                    </containedItem>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5376-04" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5376" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42957" />
                                <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EOONO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                    <package>
                        <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                            <valueReference>
                                <reference value="PackagedProductDefinition/0009-5936-01" />
                            </valueReference>
                        </extension>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                            <value value="0009-5936" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C42945" />
                                <display value="INJECTION, SOLUTION" />
                            </coding>
                        </type>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EGTNO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <unit value="mL" />
                                <system value="http://unitsofmeasure.org" /><code value="mL" />
                            </amount>
                        </containedItem>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-7200-30" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-7200-30" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">KIT (0009-7200-30</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-7200" />
                </packageFor>
                <marketingStatus>
                    <status>
                        <coding>
                            <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-splMarketingStatuses" />
                            <code value="active" />
                        </coding>
                    </status>
                    <dateRange>
                        <start value="2022-01-17" />
                    </dateRange>
                </marketingStatus>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-7200-30" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43182" />
                            <display value="CARTON" />
                        </coding>
                    </type>
                    <package>
                        <identifier>
                            <system value="http://hl7.org/fhir/sid/ndc" />
                        </identifier>
                        <type>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C43197" />
                                <display value="KIT" />
                            </coding>
                        </type>
                        <quantity value="30" />
                        <property>
                            <type>
                                <coding>
                                    <system
                                        value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                    <code value="SPLCMBPRDTP" />
                                </coding>
                            </type>
                            <valueCodeableConcept>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C112160" />
                                    <display value="Type 0: Not a Combination Product" />
                                </coding>
                            </valueCodeableConcept>
                        </property>
                        <containedItem>
                            <item>
                                <reference>
                                    <reference value="ManufacturedItemDefinition/ID0EGLNO" />
                                </reference>
                            </item>
                            <amount>
                                <value value="1" />
                                <system value="http://unitsofmeasure.org" /><code value="1" />
                            </amount>
                        </containedItem>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5376-04" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5376" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42957" />
                                    <display value="INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EOONO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                        <package>
                            <extension url="http://hl7.org/fhir/us/spl/StructureDefinition/packageInstanceOf">
                                <valueReference>
                                    <reference value="PackagedProductDefinition/0009-5936-01" />
                                </valueReference>
                            </extension>
                            <identifier>
                                <system value="http://hl7.org/fhir/sid/ndc" />
                                <value value="0009-5936" />
                            </identifier>
                            <type>
                                <coding>
                                    <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                        value="C42945" />
                                    <display value="INJECTION, SOLUTION" />
                                </coding>
                            </type>
                            <containedItem>
                                <item>
                                    <reference>
                                        <reference value="ManufacturedItemDefinition/ID0EGTNO" />
                                    </reference>
                                </item>
                                <amount>
                                    <value value="1" />
                                    <unit value="mL" />
                                    <system value="http://unitsofmeasure.org" /><code value="mL" />
                                </amount>
                            </containedItem>
                        </package>
                    </package>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/PackagedProductDefinition/0009-5376-04" />
        <resource>
            <PackagedProductDefinition>
                <id value="0009-5376-04" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalPackaging" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">VIAL, SINGLE-DOSE (0009-5376-04</div>
                </text>
                <packageFor>
                    <reference value="MedicinalProductDefinition/0009-5376" />
                </packageFor>
                <package>
                    <identifier>
                        <system value="http://hl7.org/fhir/sid/ndc" />
                        <value value="0009-5376-04" />
                    </identifier>
                    <type>
                        <coding>
                            <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C43215" />
                            <display value="VIAL, SINGLE-DOSE" />
                        </coding>
                    </type>
                    <property>
                        <type>
                            <coding>
                                <system value="http://hl7.org/fhir/us/spl/CodeSystem/codesystem-characteristicTypes" />
                                <code value="SPLCMBPRDTP" />
                            </coding>
                        </type>
                        <valueCodeableConcept>
                            <coding>
                                <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code
                                    value="C112160" />
                                <display value="Type 0: Not a Combination Product" />
                            </coding>
                        </valueCodeableConcept>
                    </property>
                    <containedItem>
                        <item>
                            <reference>
                                <reference value="ManufacturedItemDefinition/ID0EOONO" />
                            </reference>
                        </item>
                        <amount>
                            <value value="1" />
                            <unit value="mL" />
                            <system value="http://unitsofmeasure.org" /><code value="mL" />
                        </amount>
                    </containedItem>
                </package>
            </PackagedProductDefinition>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-7200" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-7200" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-7200" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/RegulatedAuthorization/RegulatedAuthorization-0009-5376" />
        <resource>
            <RegulatedAuthorization>
                <id value="RegulatedAuthorization-0009-5376" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedMedicinalProductMarketing" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">BLA 021106</div>
                </text>
                <identifier>
                    <system value="urn:oid:2.16.840.1.113883.3.150" />
                    <value value="BLA021106" />
                </identifier>
                <subject>
                    <reference value="MedicinalProductDefinition/0009-5376" />
                </subject>
                <type>
                    <coding>
                        <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl" /><code value="C73585" />
                        <display value="BLA" />
                    </coding>
                </type>
                <region>
                    <coding>
                        <system value="urn:iso:std:iso:3166" /><code value="USA" />
                    </coding>
                </region>
            </RegulatedAuthorization>
        </resource>
    </entry>
    <entry>
        <fullUrl value="http://example.org/SubstanceDefinition/N824AOU5XV" />
        <resource>
            <SubstanceDefinition>
                <id value="N824AOU5XV" />
                <meta>
                <profile value="http://hl7.org/fhir/us/spl/StructureDefinition/SubmittedIngredientDefinition" />
                </meta><text>
                    <status value="generated" />
                    <div xmlns="http://www.w3.org/1999/xhtml">PEGVISOMANT Substance</div>
                </text>
                <identifier>
                    <system value="http://fdasis.nlm.nih.gov" />
                    <value value="N824AOU5XV" />
                </identifier>
                <moiety>
                    <identifier>
                        <system value="http://fdasis.nlm.nih.gov" />
                        <value value="N824AOU5XV" />
                    </identifier>
                    <name value="PEGVISOMANT" />
                </moiety>
                <name>
                    <name value="PEGVISOMANT" />
                </name>
            </SubstanceDefinition>
        </resource>
    </entry>
</Bundle>